The programme of 24th Annual Congress of the Czech Society of

Transkript

The programme of the 24th Annual Congress of the
Czech Society of Cardiology,
Sunday 15 – Wednesday 18 May 2016
Sunday 15 May 2016
ROTUNDA (Room A)
11:00-12:00
Members´meeting of Czech Society of Cardiology I
Chairpersons: M. Táborský, P. Widimský, A. Linhart, P. Ošťádal, J. Janoušek,
M. Branny (Olomouc, Prague, Třinec)
11:00 1.
2015 CSC ACTIVITY REPORT
M. Táborský (Olomouc)
11:15 2.
REPORT ON ACTIVITIES OF CSC WORKING GROUPS/ASSOCIATIONS
J. Janoušek (Prague)
11:25 3.
2015 CSC FINANCIAL REPORT
P. Ošťádal (Prague)
11:30 4.
2015 AUDIT REPORT
M. Branny (Třinec)
11:35 5.
PROPOSAL OF CHANGES IN CSC ARTICLES
11:45 6.
DISCUSSION AND VOTING ON THE PRESENTED RESULTS
12:00
Break
14:00-15:30
Czech Association of Interventional Cardiology
Antithrombotic Therapy in Cardiac Interventions - HOW TO DO IT?
Chairpersons: M. Želízko, P. Kala (Prague, Brno)
14:00 7.
ANTITHROMBOTIC THERAPY AND ACUTE CORONARY SYNDROMES
P. Kala (Brno)
14:12 8.
ANTITHROMBOTIC THERAPY IN STRUCTURAL INTERVENTIONS
M. Želízko (Prague)
14:24 9.
ANTITHROMBOTIC THERAPY IN PATIENTS REQUIRING ANTICOAGULANTION THERAPY
R. Miklík (Brno)
14:36 10.
ANTITHROMBOTIC THERAPY IN RELATION TO CARDIAC SURGERY
J. Vojáček (Hradec Králové)
14:48 11.
ANTITHROMBOTIC THERAPY IN HIGH-RISK PATIENT GROUPS
M. Branny (Třinec)
15:00 12.
BLEEDING COMPLICATIONS AND THEIR SOLUTIONS
M. Mates (Prague)
15:12
Discussion
15:30-17:30
Live streaming
Chairpersons: P. Kala, M. Táborský, P. Widimský (Brno, Olomouc, Prague)
15:30 13.
LIVE 1: PCI OF BIFURCATION LESION UNDER THE CONTROL OF OPTICAL COHERENCE
TOMOGRAPHY
P. Červinka, R. Špaček (Ústí nad Labem)
15:52 14.
RECORDED 1: REFRACTORY CARDIAC ARREST COMPLICATING ACUTE MYOCARDIAL
INFARCTION TREATED BY MECHANICAL CHEST COMPRESSION AND CIRCULATORY
SUPPORT (ECMO) FOLLOWED BY PCI
T. Kovárník, J. Bělohlávek (Prague)
16:07 15.
LIVE 2: PERCUTANEOUS IMPLANTATION OF STENT GRAFT IN THE ABDOMINAL AORTA
S. Heller, P. Vařejka (Prague)
16:29 16.
RECORDED 2: MITRAL PARAVALVULAR LEAK CLOSURE
M. Branny, P. Branny, G. Smolka, L. Škňouřil, M. Janík, J. Januška (Třinec)
16:41 17.
LIVE 3: PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE
P. Červinka, M. Kvašňák (Ústí nad Labem)
17:03 18.
RECORDED 3: TRANSFEMORAL TRANSCATHETER AORTIC VALVE IMPLANTATION
(TAVI) AND TRANSAPICAL VALVE-IN-VALVE TAVI
P. Kala, J. Ondrášek, M. Třetina, P. Němec, P. Malík, P. Pokorný, R. Vágner (Brno)
17:15 19.
RECORDED 4: EPICARDIAL MAPPING AND ABLATION OF VENTRICULAR TACHYCARDIA
IN DILATED CARDIOMYOPATHY
M. Fiala, J. Januška (Třinec)
17:30
Break
17:45-18:45
Members´meeting of Czech Society of Cardiology II
It will only be held If Members’ Meeting I will not constitute a quorum.
The programme remains the same.
18:45
Break
19:00-20:00
OPENING CEREMONY OF THE 24TH ANNUAL CONGRESS
Chairpersons: M. Táborský, P. Widimský, A. Linhart (Olomouc, Prague)
19:00 20.
WELCOMING CEREMONY
19:05 21.
HONORARY MEMBERSHIP CEREMONY
L. Elbl, J. Popelová, I. Šimková, J. Šťásek, J. Widimský jr. (Brno, Prague, Bratislava –
Slovak Republic, Hradec Králové)
19:15 22.
LIBENSKY´S GOLD CSC MEDALS OF CEREMONY
G. Hindricks, P. Widimský (Leipzig, Germany, Prague)
19:25 23.
LIFETIME CONTRIBUTION TO CARDIOLOGY AWARD CEREMONY
M. Šamánek, J. Widimský, M. Aschermann (Praha)
19:35 24.
INAUGURAL LECTURE OF THE 24TH ANNUAL CCONGRESS:
VISUALIZATION AND DELIVERY: THE FUTURE OF CARDIOVASCULAR MEDICINE
G. Hindricks (Leipzig, Germany)
20:00
End of Programme
MORAVA (Room A3)
15:00-16:00
Advanced Heart Failure - How to Deal With it?
IKEM Cardiology Department Symposium
Chairpersons : V. Staněk, J. Kautzner (Prague)
15:00 25.
DEFINITION, PREVALENCE AND TREATMENT OPTIONS OF ADVANCED HEART FAILURE
V. Melenovský (Prague)
15:15 26.
PULMONARY HYPERTENSION IN HEART FAILURE
H. Al-Hiti (Prague)
15:30 27.
LONG-TERM MECHANICAL CIRCULATORY SUPPORT – LATEST NEWS
I. Netuka (Prague)
15:45 28.
HEART TRANSPLANTATION AND POST-TRANSPLANT CARE (INTRODUCING
NEW INFORMATION BOOKLET FOR PHYSICIANS)
L. Hošková (Prague)
16:00
Break
16:10-17:10
CARDION s.r.o. Symposium
Embolic Stroke Prevention
In Cooperation with IKEM Prague
Chairperson: J. Kautzner (Prague)
16:10 29.
PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE
16:25 30.
PERCUTANEOUS CLOSURE OF LEFT ATRIAL APPENDAGE
B. Janek (Prague)
16:40 31.
CATHETER ABLATION OF ATRIAL FIBRILLATION
P. Peichl (Prague)
16:55 32.
PHARMACOLOGICAL TREATMENT
R. Čihák (Prague)
17:10
End of Programme
BRNO (Room E – 1st floor)
14:00-15:30
Free Lectures - Nursing Session I
Chairpersons: I. Lálová, E. Zvolánková (Prague, Ostrava)
14:00 33.
PACEMAKER AND DEFIBRILLATOR LEADS EXTRACTION – PROCEDURE AND
POSTOPERATIVE CARE
K. Skákalíková, M. Stránská, P. Koblížková, J. Baroch, M. Mráček, J. Petrů, P. Neužil
(Prague)
14:09 34.
LOGISTICS OF EARLY HOSPITAL CARE OF PATIENTS WITH REFRACTORY CARDIAC
ARREST
I. Lálová, T. Sudová , M. Křečková, J. Bělohlávek (Prague)
14:18 35.
OPTIONS OF MEASURING TISSUE OXIMETRY IN PATIENTS WITH CARDIOGENIC
SHOCK
S. Šmuclerová, D. Hájková, P. Hladká, P. Ošťádal (Prague)
14:27 36.
NURSING CARE OF PATIENT WITH DELAYED STERNAL CLOSURE
L. Laciaková (Prague)
14:36 37.
TRANSCATHETER CLOSURE OF LEFT VENTRICULAR ANEURYSM WITH PARACHUTE
SYSTEM FROM NURSE’S VIEW
L. Podlašecká, R. Blažková , V. Jílková (Prague)
14:45 38.
LEFT VENTRICULAR RESTORATION PROCEDURE FROM CATHETRIZATION LAB
NURSE´S VIEW
Z. Krausová, M. Jaďuďová Pálová, G. Hartmanová, K. Kopřiva, M. Mates, P. Neužil
(Prague)
14:54 39.
CZECH PUBLIC AWARENESS OF MYOCARDIAL INFARCTION, RISK FACTORS, AND
HEALTHY LIFESTYLE
P. Hladká, J. Pokorná, S. Šmuclerová, Š. Bělunková, K. Neusserová, O. Šmolcnopová, J.
Pánková, P. Oštádal (Prague)
15:03 40.
NURSING CARE OF PAEDIATRIC PATIENT WITH CHYLOTHORAX AFTER CARDIAC
SURGERY
M. Pulkertová (Prague)
15:12 41.
CORONARY ARTERY AS WE DO NOT KNOW IT - CASE REPORT
E. Zvolánková, R. Pavelková, R. Madry (Ostrava)
15:21 42.
IMPLANTATION OF MECHANICAL CIRCULATORY SUPPORT AS A BRIDGE TO
TRANSPLANTATION IN YOUNG FEMALE PATIENTS- CASE REPORT
J. Ostrihoňová, V. Fišerová, M. Jurek, R. Šrámek (Prague)
15:30-17:40
Free Lectures - Nursing Session II
Chairpersons: P. Škárková, A. Slížková (Olomouc, Pilsen)
15:30 43.
EXPERIENCE WITH IMPLANTATION OF NEW SUBCUTANEOUS HEART RHYTHM
RECORDER REVEAL LINQ
P. Koblížková, M. Stránská, H. Vykydalová, A. Pařízková, M. Mudroch, J. Petrů, P.
Neužil (Prague)
15:39 44.
HOW LIFE CAN CHANGE IN A FEW DAYS - A MAN WITH INFECTIVE
ENDOCARDITIS: CASE REPORT
P. Škárková (Olomouc)
15:48 45.
DIFFICULTY AND POTENTIAL BENEFIT OF EVALUATION OF AUTONOMIC NERVOUS
SYSTEM BALANCE FROM HOLTER ECG MONITORING
A. Slížková, M. Šebestová, V. Vejvoda (Pilsen)
15:57 46.
APPLICATION OF CLINICAL GENETICS IN ARRHYTHMOLOGY
I. Valtrová, J. Homolová, K. Lefflerová (Prague)
16:06 47.
SPECIFICS OF NURSING CARE OF PATIENTS WITH HUMORAL REJECTION AFTER
HEART TRANSPLANTATION
I. Ledvinová, M. Náglová (Prague)
16:15 48.
LEFT VENTRICULAR REMODELING PROCEDURE BY BIOVENTRIX SYSTEM –
NURSE‘S VIEW
D. Kvapilová, K. Kratochvílová, K. Vydrová (Prague)
16:24 49.
NON-CARDIAC ISSUES IN CARDIOLOGY OUTPATIENT CLINIC- NURSE’S WORK
P. Povolná, R. Jirmář (Prague)
16:33 50.
ROLE OF CARDIAC NURSE IN CARE OF PATIENTS WITH ARRHYTHMIAS
L. Jančíková, R. Fábryová, J. Rohlíková, J. Šimek (Prague)
16:42 51.
CATHETER-BASED TREATMENT OF ARRHYTHMIAS IN CHILDHOOD
K. Kleinhamplová, M. Žižková (Prague)
16:51 52.
SUSPICIOUS FOREIGN BODY IN LEFT ATRIUM AFTER CATHETER ABLATION OF ATRIAL
FIBRILLATION
H. Grofková, T. Skála (Olomouc)
17:00 53.
UNRECOGNISED TRANSAORTIC PERMANENT PACING
(
L. Stojanová, O. Moravec (Olomouc)
17:09 54.
PACEMAKER AND DEFIBRILLATOR LEAD EXTRACTION. PATIENT PREPARATION AND
POST-PROCEDURE CARE FROM NURSE’S POINT OF VIEW.
L. Livorová, B. Valíčková (Prague)
17:18 55.
IMPLANTATION OF SUBCUTANEOUS REVEAL LINQ CARDIAC MONITOR. EXPERIENCE
OF OUR DEPARTMENT FROM NURSE’S POINT OF VIEW. INDICATIONS, PATIENT
PREPARATION, CASE REPORTS.
K. Kadlecová, K. Kemzová (Prague)
17:40
End of programme
HRADEC KRÁLOVÉ (Room E – 1st floor)
14:00-16:00
Congenital Heart Disease in Clinical Practice
Educational Workshop of Czech Society of Cardiology (Only for Signed Members of
Working Group Kardio 35)
Chairpersons: J. Popelová, J. Janoušek (Prague)
14:00 56.
TREATMENT RESULTS OF CONGENITAL HEART DISEASE IN CHILDHOOD
V. Chaloupecký (Prague)
14:15 57.
GROWN-UP CONGENITAL HEART DISEASE – OVERVIEW, EPIDEMIOLOGY
P. Antonová (Prague)
14:30 58.
ADULTS WITH UNOPERATED CONGENITAL HEART DISEASE
T. Zatočil (Brno)
14:45 59.
ADULTS AFTER CONGENITAL HEART DISEASE SURGERY
J. Popelová (Prague)
15:05 60.
ARRHYTHMIAS IN GROWN-UP CONGENITAL HEART DISEASE
J. Škoda, P. Neužil, J. Janoušek (Prague)
15:15 61.
SURGICAL TREATMENT OF CONGENITAL HEART DISEASE IN ADULTHOOD
Š. Černý, R. Gebauer (Prague)
15:30 62.
CONGENITAL HEART DISEASE AND TRANSPLANTATION
P. Němec, M. Ošmerová (Brno)
15:45
Discussion
16:00
End of programme
Monday 16 May 2016
ROTUNDA (Room A)
8:30-9:30
“Czech Society of Internal Medicine” block
Chairpersons: R. Češka, J. Widimský jr. (Prague)
8:30
63.
TABLOIDS AND THEIR IMPACT ON PATIENTS’ COMPLIANCE
R. Češka (Prague)
8:45
64.
LATEST NEWS IN INTERNAL MEDICINE IN YEAR 2015
J. Václavík (Olomouc)
9:00
65.
COMPLIANCE WITH TREATMENT IN INTERNAL MEDICINE
J. Widimský jr. (Prague)
9:15
66.
PHARMACOTHERAPY SPECIFICS IN POLYMORBID PATIENTS
M. Vrablík (Prague)
9:30-10:30
BAYER s. r. o. Symposium
Rivaroxaban: Proved in Real-World Clinical Practice
Chairperson: M. Táborský (Olomouc)
9:30
67.
PRACTICAL RECOMMENDATIONS FROM REAL-WORLD CLINICAL PRACTICE
9:45
68.
RIVAROXABAN IN PATIENTS WITH REDUCED RENAL FUNCTION
V. Tesař (Prague)
10:00 69.
PATIENT COMPLIANCE IN REAL-WORLD CLINICAL SETTINGS
K. Urbánek (Olomouc)
10:15
Discussion
10:30
Break
11:00-12:30
Boehringer Ingelheim spol. s r.o. Symposium
Dabigatran With Specific Antidote – Another Step to Safer Anticoagulation
Chairperson: P. Neužil (Prague)
11:00 70.
IDARUCIZUMAB – FIRST STEPS
P. Janský (Prague)
11:15 71.
IDARUCIZUMAB AND TRIAL REVERSE-AD
D. Tuček (Hradec Králové)
11:30 72.
INCREASING THE SAFETY OF DABIGATRAN THERAPY
M. Penka (Brno)
11:45 73.
NEED FOR ANTIDOTE IN THE REAL WORLD?
J. Kautzner (Prague)
12:00 74.
WHAT DOES ANTIDOTE BRING TO CARDIOLOGY OUTPATIENT CLINIC?
L. Elbl (Brno)
12:15
Discussion
12:30
Lunch Break
13:00-14:00
CASE REPORTS – Rivaroxaban Treatment in Real-World Clinical Settings
Chairpersons: M. Táborský, P. Widimský, J. Kautzner, H. Skalická (Olomouc, Prague)
14:00
Break
14:10-16:10
Heart Failure: Update 2016
Presidential block
Chairpersons: M. Táborský, J. Špinar (Olomouc, Brno)
14:10 75.
PATHOPHYSIOLOGY OF HEART FAILURE: BACK TO ROOTS
L. Špinarová (Brno)
14:30
Discussion
14:35 76.
ACUTE HEART FAILURE: WHEN DRUGS ARE NOT ENOUGH
14:55
Discussion
15:00 77.
PHARMACOTHERAPY OF HEART FAILURE: HOW TO HANDLE A HEART FAILURE
EPIDEMIC?
J. Vítovec, M. Lazárová (Brno, Olomouc)
15:20
Discussion
15:25 78.
MECHANICAL CIRCULATORY SUPPORT: PRESENT AND FUTURE
I. Netuka, J. Malý (Prague)
15:45
Discussion
15:50 79.
ECHOCARDIOGRAPHY IN HEART FAILURE: STANDARD THAT MUST BE
REMINDED
A. Linhart (Prague)
16:10
Break
16:20-17:50
Pfizer, spol. s r. o. Symposium
Eliquis – Balanced Efficacy and Safety (From Research to Practice)
Chairpersons: P. Neužil, J. Lopez-Sendon (Prague, Madrid, Spain)
16:20 80.
PREVENTION OF THROMBOEMBOLISM – WHAT CHALLENGES DOES CLINICAL
PRACTICE BRING?
P. Neužil (Prague)
16:35 81.
BLEEDING COMPLICATIONS ASSOCIATED WITH ANTICOAGULATION THERAPY - HOW
TO MINIMIZE THEIR OCCURRENCE?
J. Lopez-Sendon (Madrid, Spain)
17:00 82.
PATIENT WITH STROKE – HOW TO PREVENT RECURRENCE?
A. Tomek (Prague)
17:15 83.
TREATMENT OF ACUTE THROMBOEMBOLISM – HOW TO PROCEED IN OUTPATINT
CLINIC?
R. Malý (Hradec Králové)
17:30 84.
PANEL DISCUSSION
17:40 85.
SUMMARY AND END OF SYMPOSIUM
17:50
End of programme
MORAVA (Room A3)
8:30-10:30
Free Lectures - Nursing Section III
Chairpersons: T. Kulík, D. Kvasničková (Brno, Prague)
8:30
86.
PATIENT EDUCATION AFTER MYOCARDIAL INFARCTION AT CLINIC OF INTERNAL
MEDICINE – CARDIOLOGY IN THE UNIVERSITY HOSPITAL BRNO
L. Dostálová, K. Marcinechová, J. Polášková (Brno)
8:38
87.
DEVELOPMENT OF ALCOHOL SEPTAL ABLATION AFTER 10 YEARS OF PRACTICE
V. Součková (Hradec Králové)
8:46
88.
USE OF MODIFIED CIRCULATORY SUPPORT ECMO IN HIGH-RISK
INTERVENTIONS
H. Vondráčková (Hradec Králové)
8:54
89.
POSSIBILITIES OF CATHETERIZATION BACK-UP FOR CRITICALLY ILL PATIENTS BEFORE
CARDIAC SURGERY
K. Ernstová (Hradec Králové)
9:02
90.
MULTICENTRIC COLLABORATION IN TREATMENT OF PATIENTS AFTER OHT WITH
SUSPICION OF SLEEP APNEA
M. Bláhová, L. Hošková, M. Pretl, D. Kvasničková, V. Fišerová, M. Wiendl (Prague)
9:10
91.
WE HAVE A NEW ANGIOGRAPHY UNIT :-)...AND WHAT NEXT?
D. Grymová, V. Kožušníková (Ostrava)
9:18
92.
CARDIOVASCULAR MANIFESTATIONS OF FABRY DISEASE
A. Kmoníčková, H. Rakovská , J. Petřková (Olomouc)
9:26
93.
SPECIFICS OF CARE FOR PATIENTS BEFORE AND AFTER TAVI
J. Semufová, M. Matysová (Prague)
9:34
94.
CORRECT INDICATIONS FOR DIFFERENT TYPES OF LONG-TERM AMBULATORY ECG
MONITORING
D. Kvasničková, I. Tošnarová (Prague)
9:42
95.
LONG-TERM OESOPHAGEAL MOBILITY IN PATIENTS UNDERGOING CATHETER
ABLATION OF ATRIAL FIBRILLATION – DATA COMPARISON FROM CT AND AND 3D
ROTATIONAL ATRIOGRAPHY
T. Kulík, Z. Stárek, A. Žbánková, F. Lehar, J. Jež, J. Wolf (Brno)
9:50
96.
CARDIAC ARREST IN ACUTE CORONARY SYNDROME OR WHAT HOPE IS THERE FOR
HEART
M. Navrátilová, J. Malík, A. Sedláčková, D. Paďourková, V. Šťáhlavská (Prague)
9:58
97.
WOLFF-PARKINSON-WHITE SYNDROME AS SEVERE ARRHYTHMIA
M. Navrátilová, J. Malík (Prague)
10:06 98.
CURRENT OPTIONS FOR NON-INVASIVE CARDIOLOGY IN IKEM FROM NURSE’S VIEW
R. Langová, K. Králová, P. Houbová, V. Šikula (Prague)
10:14 99.
USE OF CONTINUOUS ELIMINATION METHODS IN PATIENT WITH CARDIOGENIC
SHOCK
K. Neusserová, K. Kondrašová, P. Ošťádal, A. Kruger, J. Myšková (Prague)
10:30
Break
11:00-12:30
Working Group of Cardiology Nurses and Allied Professions
New Trends in Cardiovascular Nursing
Chairpersons: L. Klemsová, D. Křivská, D. Hetclová, J. Doležel (Ostrava, Prague,
Olomouc)
11:00 100.
ACUTE CARDIOLOGY – WHERE WE ARE AND WHERE WE ARE GOING
M. Hutyra (Olomouc)
11:20 101.
A STEP TO IMPROVE QUALITY OF LIFE IN PATIENTS WITH REMODULIN –
IMPLANTABLE INFUSION PUMP
D. Hetclová (Olomouc)
11:30 102.
ICD INSTEAD OF LIFE INSURANCE
L. Golasovská, T. Stašková (Ostrava)
11:40 103.
NEWBORN WITH AORTIC STENOSIS
J. Látrová, L. Jedličková (Prague)
11:50 104.
AIRWAY INFLAMMATION, BANALITY OR THE BEGINNING OF FIGHT FOR LIFE?
M. Hrubá, H. Lukšová (Ostrava)
12:00 105.
SUPERVISION AND EDUCATION OF CZECH NURSES IN CAMBODGA
L. Laciaková, N. Blaškovanová, T. Tláskal (Prague)
12:10 106.
SUPERVISION AND EDUCATION OF CZECH NURSES IN CAMBODGA – CASE REPORT
N. Blaškovanová (Prague)
12:30
Lunch break
13:00-14:00
Medtronic Czechia s.r.o. Symposium
TAVI – frequently asked questions
Chairpersons: M. Aschermann, M. Branny (Prague, Třinec)
13:00 107.
INDICATIONS: TAVI IN MODERATE-RISK PATIENTS
M. Mates (Prague)
13:10 108.
WHAT TO MONITOR IN PATIENT AFTER TAVI?
I. Bernat (Pilsen)
13:20 109.
WHEN SURGEON CHANGES INDICATION FROM SAVR TO TAVI
.
M. Branny (Třinec)
13:30 110.
VALVE-IN-VALVE: END OF REOPERATIONS?
13:40 111.
VALVE REPOSITIONING - NEW TREATMENT OPTIONS
V. Kočka (Prague)
13:50 112.
Discussion
M. Branny (Třinec)
14:00
Break
14:10-15:10
Free Lectures - Secondary Prevention, Arrhythmias, Cardiac Rehabilitation
Chairpersons: J. Siegelová, J. Jakabčin (Brno, Ústí nad Labem)
14:10 113.
CATHETER ABLATION OF ISCHAEMIC VENTRICULAR TACHYCARDIA BY REMOTE
MAGNETIC NAVIGATION: STOP-VT MULTICENTRE STUDY (STUDY TO OBLITERATE P
ERSISTENT VENTRICULAR TACHYCARDIA)
J. Škoda, P. Neužil, A. Arya, E. Gerstenfeld, F. Garcia, J. Petrů, L. Šedivá, J. Miller, V.
Reddy (Prague, Leipzig, Germany, San Francisco, United States, Philadelphia, United
States, Bloomintgton, United States, New York, United States)
14:20 114.
DIAGNOSTIC YIELD OF LONG-TERM NONINVASIVE TRANSTELEPHONIC ECG
ELECTROMONITORING: RESULTS OF 4-YEAR STUDY IN 4 811 PATIENTS
V. Bulková, J. Gandalovičová, J. Šimek, D. Wichterle, J. Chovančík, P. Neužil, O.
Toman, P. Vít, J. Kautzner, M. Fiala (Brno, Prague, Třinec)
14:30 115.
TOBACCO ADDICTION TREATMENT - STANDARD OF CARDIOLOGY CARE,
POSSIBILITIES IN THE CZECH REPUBLIC
E. Králíková (Prague)
14:40 116.
REDUCED QUALITY OF LIFE INDEX (SF-36 SCORE) AS MORTALITY PREDICTOR IN
STABILIZED PATIENTS AFTER FIRST ISCHAEMIC STROKE
J. Vaněk, L. Kielbergerová , O. Mayer, J. Bruthans, P. Wohlfahrt, R. Cífková (Pilsen,
Prague)
14:50 117.
SPA TREATMENT AND ITS EFFECT ON RISK PROFILE OF PATIENTS WITH CHRONIC
CORONARY HEART DISEASE IN EUROASPIRE II STUDY
J. Vaněk, O. Mayer, J. Bruthans, R. Cífková (Pilsen, Prague)
15:00 118.
INTRODUCING THE CONCEPT OF CARDIOVASCULAR REHABILITATION IN FIONA
STANLEY HOSPITAL - PERTH, WESTERN AUSTRALIA
R. Vysoký, A. Maiorana (Brno, Perth, Australia)
15:10-16:10
Free Lectures - Heart Failure
Chairpersons: F. Málek, J. Pařenica (Prague, Brno)
15:10 119.
DIAGNOSTICS AND CLINICAL PRESENTATION OF DANON DISEASE IN CZECH REPUBLIC
M. Kubánek, A. Krebsová, L. Piherová, J. Sikora, S. Kmoch, M. Macek jr., T. Paleček, V.
Stará, V. Melenovský, J. Kautzner (Prague)
15:20 120.
CATHETER IMPLANTATION OF PARACHUTE SYSTEM – LEFT VENTRICULAR
RESTORATION (PVR) – FIRST EXPERIENCE
P. Neužil, V. Reddy, P. Kmoníček, J. Petrů, J. Naar, P. Doškář, T. Mráz, A. Krüger, M.
Mates, M. Prokopová (Prague, Boston, United States)
15:30 121.
MINIMALLY INVASIVE TRANSCATHETER LEFT VENTRICULAR RESTORATION (TCVR)
P. Neužil, I. Skalský, A. Krüger, T. Mráz, M. Mates, T. Martinča, P. Kmoníček,
K.Kopřiva (Prague)
15:40 122.
HEART FAILURE IS ASSOCIATED WITH DECREASED IRON CONTENTS IN THE
MYOCARDIUM AND MITOCHODNDRIAL DYSFUNCTION: RESULTS OF DIRECT TISSUE
ANALYSIS
V. Melenovský, J. Petrák, T. Mráček, J. Beneš, H. Nusková, T. Pluháček, J. Špaténka, J.
Kautzner, J. Pirk, J. Houštěk (Prague, Olomouc)
15:50 123.
RELATION OF CERULOPLASMIN CONCENTRATION TO CONCENTRATION OF HEART
REMODELING AND MYOFIBROSIS BIOMARKERS: NT-PROBNP, SST2 A GALECTIN-3 IN
PATIENTS WITH STABLE CHRONIC HEART FAILURE AND REDUCED LEFT VENTRICULAR
EJECTION FRACTION
F. Málek, D. Vondráková, L. Sedláčková, J. Dvořák, T. Andreasová, L. Táborský, P.
Neužil (Prague)
16:00 124.
CATHETER-BASED TREATEMENT OF AORTIC REGURGITATION BY MITRACLIP IN
PATIENTS WITH CHRONIC CARDIAC INSUFFICIENCY
V. Pořízka, M. Želízko, R. Kočková, M. Hrnčárek (Prague)
16:10
Break
16:20-17:20
“Society for Organ Transplantation ČLS JEP“ block
Chairpersons: J. Malý, O. Viklický (Prague)
16:20 125.
ABDOMINAL SOLID ORGAN TRANSPLANTATION - CURRENT STATUS
P. Trunečka (Prague)
16:40 126.
INDIVIDUALIZATION OF IMMUNOSUPPRESSION AFTER TRANSPLANTATION
O. Viklický (Prague)
17:00 127.
INFECTIOUS COMPLICATIONS AFTER SOLID ORGAN TRANSPLANTATION
M. Ročeň (Prague)
17:20
Break
17:30-18:30
Free Lectures - Arrhythmias
Chairpersons: L. Haman, L. Šedivá (Hradec Králové, Prague)
17:30 128.
RELATIONSHIP BEWTEEN THE SIZE OF LEFT ATRIUM ASSESSED BY CT,
ECHOCARDIOGRAPHY AND ELECTROANATOMICAL MAPPING IN PATIENTS WITH
ATRIAL FIBRILLATION
Š. Havránek, Z. Fingrová, J. Marek, V. Bulková, J. Šimek, D. Wichterle, A. Linhart
(Prague)
17:40 129.
LOW PREVALENCE OF RECONNECTION OF PULMONARY VEINS AND ACTIVE SOURCES
FROM PULMONARY VEINS IN THE FIRST REPEATED ABLATION FOR PRIMARY LONGTERM PERSISTENT ATRIAL FIBRILLATION
M. Fiala, O. Toman, L. Rybka, V. Bulková, L. Škňouřil, J. Januška, J. Špinar (Třinec,
Brno, Prague)
17:50 130.
UPDATE OF COMPLICATIONS OF CATHETER ABLATION FOR PAROXYSMAL
FIBRILLATION: ANALYSIS OF 1287 PROCEDURES IN 946 PATIENTS
M. Fiala, L. Rybka, L. Škňouřil, J. Chovančík, R. Neuwirth, O. Jiravský, J. Januška, O.
Toman, J. Špinar (Třinec, Brno)
18:00 131.
MEASURING TEMPERATURE IN OESOPHAGEUS DURING PULMONARY VEIN
ISOLATION BY MEANS OF LASERBALLOONS , EXPERIENCE OF ONE DEPARTMENT
L. Šedivá, M. Janotka, M. Chovanec, J. Petrů, J. Škoda, P. Neužil (Prague)
18:10 132.
UP-TO-NOW RESULTS OF GENETIC TESTING IN PATIENTS WITH ARVC / D IN IKEM,
PILOT STUDY
A. Krebsová, L. Piherová, J. Paděrová, M. Segeťová, J. Kautzner, M. Macek Sr., M.
Macek Jr. (Prague)
18:20 133.
HEART EXAMINATION USING MAGNETIC RESONANCE IMAGING IN PATIENTS WITH
IMPLANTED SUBCUTANEOUS DEFIBRILLATOR (S-ICD)
P. Neužil, J. Keller, M. Janotka, J. Vymazal, J. Weichet, J. Brada, M. Mudroch, P.
Moučka, R. Žáček (Prague)
18:30
End of programme
PRAHA (Room E – 1st floor)
8:30-9:30
Working Group of Cardiovascular Pharmacotherapy
Difficult Topics in Cardiovascular Pharmacotherapy
Chairpersons: M. Malý, J. Vítovec (Prague, Brno)
8:30
134.
COMBINED ANTICOAGULATION AND ANTIPLATELET THERAPY
M. Malý (Prague)
8:50
135.
NEW ORAL ANTICOAGULANTS - ANTIDOTES
P. Janský (Prague)
9:10
136.
CARDIOTOXICITY OF DRUGS
J. Vítovec (Brno)
9:30-10:30
Czech Society for Hypertension
Target Blood Pressure Levels in Arterial Hypertension Treatment
Chairpersons: M. Souček, H. Rosolová (Brno, Pilsen)
9:30
137.
WHAT HAVE WE LEARNT ABOUT TARGET LEVELS FROM SPRINT TRIAL
J. Filipovský (Pilsen)
9:45
9:50
Discussion
138.
TARGET BLOOD PRESSURE LEVELS IN STROKES
R. Cífková (Prague)
10:05
Discussion
10:10 139.
TARGET BLOOD PRESSURE LEVELS IN HEART FAILURE
J. Špinar (Brno)
10:25
Discussion
10:30
Break
11:00-12:00
AstraZeneca Czech Republic s.r.o. Symposium
PEGASUS – With a Winged Stallion for a Better Tomorrow in Patients after
Myocardial Infarction
Chairperson: M. Táborský (Olomouc)
11:00 140.
CURRENT GUIDELINES AND TICAGRELOR FOR ACUTE CORONARY SYNDROMES
P. Widimský (Prague)
11:15 141.
REASONS FOR PROLONGED DUAL ANTIPLATELET THERAPY
Z. Moťovská (Prague)
11:30 142.
IMPORTANCE OF PEGASUS TRIAL AND NEW INDICATION FOR TICAGRELOR
J. Špinar (Brno)
11:45
Discussion
12:00
Break
13:00-14:00
SERVIER s.r.o. Symposium
1 Step For Cardiovascular Risk Treatment, 6000 Steps For Life... Or It Has Never Been
Simplier
Chairperson: A. Linhart (Prague)
13:00 143.
NEVER GIVE UP OR PATIENT’S MOTIVATION TO CHRONIC DISEASE TREATMENT
H. Rosolová (Pilsen)
13:20 144.
POLYPILL - SCIENCE FICTION OR REALITY?
13:40 145.
THE BEST OF EBM FOR SIMPLIER TREATMENT OF PATIENTS WITH HYPERTENSION
AND DYSLIPIDEMY
A. Linhart (Prague)
14:00
Break
14:10-15:10
Working Group of Preventive Cardiology
DEPRESSION AS A RISK FACTOR FOR CARDIOVASCULAR DISEASES
Chairpersons: R. Cífková, H. Rosolová (Prague, Pilsen)
14:10 146.
DEPRESSION AND CARDIOVASCULAR DISEASES
C. Höschl (Prague)
14:30 147.
PREVALENCE OF DEPRESSION AND ANXIETY IN PATIENTS AFTER STROKE
J. Bruthans, R. Cífková (Prague)
14:50 148.
RELATIONSHIP BETWEEN DEPRESSION AND METABOLIC SYNDROME IN PILSEN
POPULATION SAMPLE
H. Rosolova, J. Podlipný , F. Šefrna (Pilsen)
15:05
Disccussion
15:10-16:10
Czech Association for Heart Rhythm
Emergencies in Arrhythmology
Chairpersons: V. Vančura, L. Šedivá (Pilsen, Prague)
15:10 149.
SYNCOPE
L. Šedivá (Prague)
15:25
Discussion
15:30 150.
FAULTS OF IMPLANTABLE DEVICES
V. Vančura (Pilsen)
15:45
Discussion
15:50 151.
ELECTRICAL STORM
P. Peichl (Prague)
16:05
Discussion
16:10
Break
16:20-17:20
Sanofi-aventis, s.r.o. Symposium
PCSK9i – what can we expect?
Chairperson: A. Linhart (Prague)
16:20 152.
PCSK9 INHIBITORS: FROM MECHANISM OF ACTION TO CLINICAL USE
16:35 153.
PCSK9I – HOPE IN SECONDAR PREVENTION
A. Linhart (Prague)
16:50 154.
ALIROCUMAB IN THE LIGHT OF CLINICAL TRIALS
R. Češka (Prague)
17:05
Discussion
17:20
End of programme
8:30-9:30
Czech Association of Heart Failure
Current Status of Natriuretic Peptides
Chairpersons: J. Pařenica, V. Melenovský (Brno, Prague)
8:30
155.
NATRIURETIC PEPTIDES – PATHOPHYSIOLOGY AND NORMS
J. Špinar (Brno)
8:50
156.
FACTORS INFLUENCING THE LEVEL OF NATRIURETIC PEPTIDS
R. Pudil (Hradec Králové)
9:10
157.
TRETMENT ACCORDING TO NATRIURETIC PEPTID
F. Málek (Prague)
9:30-10:30
Boston Scientific CR Symposium
NEWS IN STRUCTURAL DISEASE TREATMENT
Chairperson: P. Červinka (Ústí nad Labem)
9:30
158.
LEFT ATRIAL APPENDAGE CLOSURE OR WHICH OCCLUDER FOR WHICH ANATOMY?
M. Branny (Třinec)
9:45
159.
ROLE OF LEFT ATRIAL APPENDAGE CLOSURE IN THE AGE OF NOACs
P. Neužil (Prague)
10:00 160.
LEFT ATRIAL APPENDAGE CLOSURE IN “CHALLENGING ANATOMY“ (CASE
REPORT/LIVE-IN-BOX)
J. Chovančík (Třinec)
10:10 161.
TAVI – INOVATIONS 2015
P. Červinka (Ústí nad Labem)
10:20 162.
TAVI REGISTRY 2015
P. Kala (Brno)
10:30
Break
11:00-12:30
Pfizer, spol. s r. o. Symposium
Anticoagulated Patient - Multidisciplinary Approach Focusing on Practical Questions
of NOACs Use
Chairpersons: A. Tomek, T. Kvasnička (Prague)
11:00 163.
CARDIOLOGIST’S VIEW
J. Večeřa (Pardubice)
11:20 164.
GASTROENTEROLOGIST’S VIEW
J. Šťovíček (Prague)
11:40 165.
NEPHROLOGIST’S VIEW
J. Orság (Olomouc)
12:00
Discussion
12:30
Lunch Break
13:00-14:00
Merck spol s r.o. Symposium
Cardiovascular Continuum and Place of Patient
Chairperson: M. Souček (Brno)
13:00 166.
CARDIOVASCULAR RISK FACTORS AND THEIR CUMULATION
13:10 167.
BETA-BLOCKERS FROM HYPERTENSION TO CORONARY ARTERY DISEASE
M. Souček (Brno)
13:20 168.
LONG-TERM BETA-BLOCKER THERAPY AFTER MI - YES
J. Vítovec (Brno)
13:25 169.
CHRONIC HEART FAILURE – THE END OR THE BEGINNING?
F. Málek (Prague)
13:35 170.
LONG-TERM BETA-BLOCKER THERAPY AFTER MI - NO
J. Špinar (Brno)
13:45
Discussion
14:00
Break
14:10-15:10
What Have New Guidelines for Interventional Cardiology Brought in Practice
Chairpersons: M. Želízko, M. Mates (Prague)
14:10 171.
CASE REPORT – STABLE CAD
R. Štípal (Ostrava)
14:15 172.
SUMMARY OF THE GUIDELINES FOR MYOCARDIAL REVASCULARIZATION
P. Kala (Brno)
14:27 173.
CASE REPORT – NSTEMI
14:32 174.
SUMMARY OF THE GUIDELINES FOR NSTEMI
V. Rozsíval (Pardubice)
14:44 175.
THE REALITY OF USING SCORING ALGORITHMS FOR ASSESSMENT OF RISK
D. Horák (Liberec)
14:54 176.
SPECIFIC AND RISK GROUPS OF PATIENTS AND REVASCULARIZATION
15:04
Discussion
15:10-16:10
Valve Interventions in Problematic Situations
Chairpersons: M. Branny, P. Červinka, V. Kočka, M. Želízko, J. Šťásek, M. Mates, P.
Němec (Třinec, Ústí nad Labem, Prague, Hradec Králové, Brno)
15:10 177.
PATIENT WITH AORTIC STENOSIS AND ANOTHER SEVERE VALVE DISEASE
15:15
Discussion
15:30 178.
ASYMPTOMATIC PATIENT WITH CRITICAL AORTIC STENOSIS
M. Branny (Třinec)
15:35
Discussion
15:50 179.
ONCOLOGICAL PATIENT WITH SEVERE AORTIC STENOSIS
J. Bis (Hradec Králové)
15:55
Discussion
16:10
Break
16:20-17:50
MODERN TREATMENT OF HEART FAILURE
In Cooperation with Czech Association for Heart Rhythm and Czech Association of
Interventional Cardiology
Chairpersons: J. Špinar, J. Hradec, M. Táborský (Brno, Prague, Olomouc)
16:20 180.
NEWS IN HEART FAILURE DIAGNOSTICS
J. Hradec (Prague)
16:35 181.
NEWS IN PHARMACOLOGICAL TREATMENT OF HEART FAILURE
J. Špinar (Brno)
16:50 182.
WHEN TO PERFORM CORONARY ANGIOGRAPHY IN PATIENT WITH SYMPTOMS OF
ACUTE HEART FAILURE
17:05 183.
POSSIBILITIES OF CATHETER-BASED INTERVENTION OF STRUCTURAL HEART
DISEASSES IN PATIENTS WITH SYMPTOMS OF ACUTE HEART FAILURE
J. Šťásek (Hradec Králové)
17:20 184.
ROLE OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN TREATMENT OF HEART
FAILURE
J. Škoda (Prague)
17:35 185.
CARDIAC RESYNCHRONIZATION THERAPY FOR HEART FAILURE: HOW TO MINIMIZE
RISK OF NONRESPONSE
K. Sedláček (Prague)
17:50
End of programme
PLZEŇ (Room E 2nd floor)
8:30-9:30
Free Lectures - Pacemakers
Chairpersons: M. Fedorco, M. Novák (Olomouc, Brno)
8:30
186.
“LEADLESS“ CARDIAC PACING – RESULTS OF VALIDATION STUDIES PERFORMED AT
ONE CENTRE
P. Neužil, L. Šedivá, J. Petrů, M. Janotka, M. Chovanec, P. Hála, J. Šorf, M. Trégler, M.
Mudroch, J. Baroch (Prague)
8:40
187.
LEADLESS STUDY – FOLLOW-UP OF FIRST 24 PATIENTS AFTER IMPLANATATION OF
“LEADLESS” PACEMAKER
J. Petrů, L. Šedivá, M. Janotka, M. Chovanec, J. Škoda, J. Šimon, V. Reddy, P. Neužil
(Prague, New York, United States)
8:50
188.
HYPERSENSITIVITY TO MATERIAL AND ENVIRONMENTAL BURDEN IN PATIENTS WITH
LATE COMPLICATIONS OF ACTIVE IMPLANTS
J. Maňoušek, I. Andršová, J. Vlašínová, M. Sepši (Brno)
9:00
189.
MID-TERM RESULTS OF PATIENTS FOLLOW-UP WITH ENDOCARDIAL “LEADLESS”
LEFT VENTRICULAR PACING
J. Petrů, L. Šedivá, J. Škoda, M. Chovanec, M. Janotka, P. Šedivý, J. Šimon, V. Reddy, P.
Neužil (Prague, New York, United States)
9:10
190.
MID-TERM STABILITY OF EPICARDIAL LEFT VENTRICULAR LEADS FOR CARDIAC
RESYNCHRONIZATION THERAPY
M. Fedorco, A. Bulava, P. Šantavý, V. Lonský, A. Mokráček, L. Dušek, M. Táborský
(Olomouc, České Budějovice, Brno)
9:20
191.
ONE DEPARTMENT’S LONG-TERM EXPERIENCE WITH LEAD EXTRACTION
L. Šedivá, M. Janotka, M. Chovanec, J. Petrů, J. Škoda, P. Neužil (Prague)
9:30-10:30
Young Cardiologists Competition
Chairpersons: A. Linhart, M. Aschermann, L. Špinarová (Prague, Brno)
9:30
192.
SPECTROSCOPIC ANALYSIS OF ATHEROSCLEROTIC PLAQUE AFTER STENT
BIORESORPTION
M. Horváth, C. Štěchovský, P. Hájek, R. Adlová, P. Tomašov, J. Veselka (Prague)
9:42
193.
PATENT FORAMEN OVALE IS AN INDEPENDENT RISK FACTOR FOR UNPROVOKED
DECOMPRESSION EVENTS IN RECREATIONAL DIVERS
J. Honěk, A. Tomek, M. Šrámek, L. Šefc, J. Januška, J. Fiedler, M. Horváth, Š. Novotný,
T. Honěk, J. Veselka (Prague, Třinec, Kladno)
9:54
194.
OUTCOME OF INFANTS WITH SEVERE LEFT VENTRICULAR FAILURE AND
STRUCTURALLY NORMAL HEART
K. Koubský, V. Tomek, P. Vojtovič, R. Gebauer, J. Janoušek, V. Chaloupecký (Prague)
10:06 195.
IMPORTANCE OF RESTING AND STRESS-INDUCED HYPERTENSION OF LEFT ATRIUM IN
PATIENTS WITH ATRIAL FIBRILLATION
M. Šramko, D. Wichterle, V. Melenovský, M. Clemens, M. Fukunaga, P. Peichl, R.
Čihák, B. Aldhoon, J. Kautzner (Prague)
10:18 196.
ROLE OF ADDING SPIRONOLACTONE AND RENAL DENERVATION IN “TRUERESISTANT” HYPERTENSION. 1-YEAR RESULTS OF RANDOMIZED STUDY PRAGUE-15
J. Rosa, P. Widimský, P. Waldauf, T. Zelinka, M. Táborský, P. Toušek, O. Petrák, R.
Holaj, M. Branny, J. Widimský jr. (Prague, Olomouc, Třínec)
10:30
Break
11:00-12:30
Young Cardiologists Competition
Chairpersons: A. Linhart, M. Aschermann, L. Špinarová (Prague, Brno)
11:00 197.
ANALYSIS OF PERIPROCEDURAL BLEEDING RISK FACTORS IN PATIENTS UNDERGOING
CORONARY ANGIOGRAPHY/PCI WITH FOCUS ON GENETIC VARIABILITY OF MAJOR
PLATELET PROTEINS.
M. Sionová, P. Blaško, Š. Jirouš, D. Vindiš, R. Rokyta, Z. Moťovská (Prague, Ostrava,
Pilsen, Olomouc)
11:12 198.
RESULTS OF PATIENTS OVER SIXTY YEARS OLD WITH HYPERTROPHIC
CARDIOMYOPATHY AFTER ALCOHOL SEPTAL ABLATION
D. Jahnlová, P. Tomašov, J. Veselka (Prague)
11:24 199.
EFFECT OF SPINAL CORD STIMULATION ON CARDIAC SYMPATHETIC NERVOUS
ACTIVITY ASSESSED BY 123I-MIBG SCINTIGRAPHY IN PATIENTS WITH HEART FAILURE
J. Naar, M. Stöhlberg, P. Doškář, F. Málek, D. Jaye, C. Linde, F. Braunschweig, D.
Bone, O. Lang, P. Neužil (Prague, Stockholm, Sweden, Minneapolis, United States)
11:36 200.
ASSESSMENT OF ATHEROSCLEROTIC PLAQUE LIPID CORE IN CAROTID STENTING
BY INFRARED SPECTROSCOPY AND INTRAVASCULAR ULTRASOUND
C. Štěchovský, P. Hájek, M. Horváth, M. Špaček, J. Veselka (Prague)
11:48 201.
PROGNOSTIC FACTORS IN COMATOSE PATIENTS AFTER OUT-OF-HOSPITAL CARDIAC
ARREST
M. Kleissner, J. Kettner, J. Kohoutek, J. Kautzner (Prague)
12:00 202.
THE ASSESSMENT COMMITEE MEETING AND ANNOUNCEMENT OF RESULTS
12:30
Lunch Break
13:00-14:00
Complex Care for Patients with Genetic Aortic Diseases
Supported by AstraZeneca Edducational Grant
Chairperson: J. Pirk (Prague)
13:00 203.
GENETICS OF AORTIC SYNDROMES
A. Krebsová (Prague)
13:15 204.
USE OF IMAGING METHODS IN PATIENTS WITH MARFAN SYNDROME
R. Kočková (Prague)
13:25 205.
SURGICAL TREATMENT
J. Malý (Prague)
13:35 206.
LONG-TERM CARE FOR THESE PATIENTS
M. Jonák (Prague)
13:45
Discussion
14:00
Break
14:10-15:10
Working Group of Myocardial and Pericardial Diseases
Diagnostics and Treatment of Pericardial Diseases
Chairpersons: T. Paleček, V. Melenovský (Prague)
14:10 207.
CLASSIFICATION AND CLINICAL PRESENTATION OF PERICARDIAL PATHOLOGIES
M. Hutyra (Olomouc)
14:25 208.
MULTIMODALITY IMAGING OF PERICARDIAL DISEASES
R. Panovský (Brno)
14:40 209.
PHARMACOLOGICAL TREATMENT OF PERICARDITIS
T. Paleček (Prague)
14:55 210.
SURGICAL TREATMENT OF PERICARDIAL DISEASES
T. Grus (Prague)
15:10-16:10
Differential Diagnosis of Cardiomyopathies
Chairpersons: J. Krejčí, P. Kuchynka (Brno, Prague)
15:10 211.
HYPERTROPHIC CARDIOMYOPATHY
D. Zemánek (Prague)
15:30 212.
DILATED CARDIOMYOPATHY
M. Kubánek (Prague)
15:50 213.
RESTRICTIVE CARDIOMYOPATHY
J. Krejčí (Brno)
16:10
Break
16:20-17:20
Interventional Cardiology and Cardiac Surgery in Patients > 80
Chairpersons: M. Mates, R. Štípal (Prague, Ostrava)
16:20 214.
SPECIFICS OF ELDERLY POPULATION AND FRAILTY SYNDROM
R. Štípal (Ostrava)
16:30 215.
CARDIAC ANESTHESIOLOGIST’S VIEW
P. Plášil (Prague)
16:40 216.
PERCUTANEOUS CORTONARY INTERVENTION
I. Bernat (Pilsen)
16:50 217.
SURGICAL REVASCULARIZATION IN THE ELDERLY
17:00 218.
PERCUTANEOUS STRUCTURAL INTERVENTION
M. Branny (Třinec)
17:10 219.
PANEL DISCUSSION, END OF PROGRAMME
M. Mates (Prague)
17:20
Break
17:30-18:30
Non-pharmacological HOT LINES - Interventions and Arrhythmias
Chairpersons: J. Šťásek, M. Želízko, M. Mates (Hradec Králové, Prague)
17:30 220.
PLACEMENT OF AORTIC TRANSCATHETER VALVES (PARTNER II)
J. Šťásek (Hradec Králové)
17:37 221.
RANDOMIZED EVALUATION OF RECCURENT STROKE COMPARING PFO CLOSURE TO
ESTABLISHED CURRENT STANDARD OF CARE TREATMENT (RESPECT); EXTENDED
FOLLOW-UP RESULTS
M. Mates (Prague)
17:44 222.
BIODEGRADABLE STENTS, CURRENT DATA
17:51 223.
IN STABLE ANGINA PCI IS BETTER THAN PHARMACOLOGICAL TREATMENT ONLY
(NOTES TO META-ANALYSIS)
V. Rozsíval (Pardubice)
17:58 224.
GUIDELINES – SUDDEN DEATH
18:05 225.
CZECH REGISTRY OF PACEMAKERS
18:10 226.
CZECH REGISTRY OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICD)
J. Bytešník (Prague)
18:15 227.
CZECH REGISTRY OF CATHETER ABLATIONS
R. Čihák (Prague)
18:20 228.
PERCUTANEOUS IMPLANTATION OF AN ENTIRELY INTRACARDIAC LEADLESS
PACEMAKER (LEADLESS II) MICRA TRANSCATHETER PACING STUDY
P. Neužil (Prague)
18:30
End of programme
OLOMOUC (Room E – 1st floor)
8:30-9:30
Coagulation
In Cooperation with Czech Society for Thrombosis and Haemostasis
Chairperson: J. Kvasnička (Prague)
8:30
229.
MECHANISMS OF HAEMOSTASIS 2016 – WHAT A CARDIOLOGIST SHOULD KNOW
J. Kvasnička (Prague)
8:45
230.
HAEMORRHAGIC CONDITIONS - DIAGNOSIS AND TREATMENT
M. Penka (Brno)
9:00
231.
THROMBOPHILIA AND THROMBOTIC EVENTS - DIAGNOSIS AND TREATMENT
T. Kvasnička (Prague)
9:15
232.
ANTIPHOSPHOLIPID SYNDROME
A. Buliková (Brno)
9:30-10:30
Free Lectures - Pacemakers, Arrhythmias
Chairpersons: P. Pařízek, R. Polášek (Hradec Králové, Liberec)
9:30
233.
LONG-TERM RESULTS OF CATHETER ABLATION FOR ATRIAL FIBRILLATION AND
FACTORS AFFECTING ITS EFFICACY
D. Wichterle, P. Peichl, B. Aldhoon, M. Šramko, P. Hajdušek, E. Borišincová, R. Čihák,
9:40
234.
CATHETER ABLATION IN PRESENCE OF PREVIOUSLY IMPLANTED LEFT ATRIAL
APPENDAGE OCCLUDER
P. Hála, M. Chovanec, M. Janotka, T. Mráz, J. Petrů, M. Prokopová, L. Šedivá, J. Škoda,
P. Neužil (Prague)
9:50
235.
OUR EXPERIENCE WITH LEADLESS CARDIAC PACING
J. Šimon, E. Kronusová, J. Petrů, P. Neužil (Prague)
10:00 236.
NEW METHOD FOR VENTRICULAR DYSSYNCHRONY DETECTION
J. Lipoldová, M. Novák, P. Leinveber, T. Reichlová, J. Halámek, P. Jurák (Brno)
10:10 237.
ARE PATIENTS AFTER CARDIAC SURGERY APPROPRIATELY INDICATED FOR CARDIAC
PACING THERAPY ?
M. Válek, Z. Fingrová, M. Smola, M. Pšenička, A. Linhart (Prague)
10:20 238.
FACTORS RELATED TO THE NEED FOR PERMANENT PACEMAKER AFTER HEART
TRANSPLANT
K. Lefflerová, I. Málek, V. Melenovský, J. Pirk, E. Pokorná, J. Kautzner (Prague)
10:30
Break
11:00-12:30
Czech Association of Acute Cardiology
Cardiac Arrest
In Cooperation with Czech Resuscitation Council
Chairpersons: A. Truhlář, T. Janota, T. Kovárník, J. Bělohlávek, P. Ošťádal (Hradec
Králové, Prague)
11:00 239.
NEWS IN RECOMMENDATIONS FOR CARDIOPULMONARY RESUSCITATION 2015
A. Truhlář (Hradec Králové)
11:30 240.
MECHANICAL CHEST COMPRESSION
T. Kovárník (Prague)
11:45 241.
REFRACTORY CARDIAC ARREST – EXTRACORPOREAL RESUSCITATION
J. Bělohlávek (Prague)
12:00 242.
CENTRES FOR PATIENTS AFTER CARDIAC ARREST ("CARDIAC ARREST CENTRES")
12:15
Discussion
12:30
Lunch break
13:00-14:00
Free Lectures - Interventional Cardiology I
Chairpersons: J. Kaňovský, F. Bednář (Brno, Prague)
13:00 243.
AORTIC STENOSIS – LONG-TERM RESULTS AFTER TRANSCATHETER AORTIC VALVE
IMPLANTATION IN HIGH-RISK PATIENTS
M. Želízko, B. Janek, M. Hrnčárek, L. Barčiaková (Prague)
13:12 244.
MID-TERM RESULTS OF MITRACLIP IMPLANTATION
J. Januška, M. Hudec, L. Škňouřil, M. Dorda, L. Gajdůšek, M. Urban, M. Bílka, M.
Branny (Třinec)
13:24 245.
ENDOVASCULAR TREATMENT OF ACUTE CEREBRAL INFARCTION IN CARDIOCENTRE
NITRA – ANALYSIS OF RESULTS OF MECHANICAL THROMBECTOMIES IN YEARS 20142015
P. Kurray, P. Blaško, M. Vytiska, M. Hranai, D. Viszlayová, A. Petrovičová, M. Brozman
(Nitra, SR)
13:36 246.
ACUTE INJURIES AND MID-TERM CHANGES OF RADIAL ARTERY AFTER
PCI ASSESSED BY OCT
J. Kaňovský, R. Miklík, T. Nováková, L. Přívarová, M. Poloczek, O. Boček, P. Jeřábek, J.
Jarkovský, P. Kala (Brno)
13:48 247.
INVASIVE MEASUREMENT OF ACUTE HAEMODYNAMIC CHANGES EARLY AFTER
MITRACLIP IMPLANTATION
F. Bednář, V. Kočka, T. Buděšínský, H. Línková, P. Toušek (Prague)
14:00
Break
14:10-15:10
Free Lectures - Interventional Cardiology II
Chairpersons: P. Toušek, J. Škvařil (Prague)
14:10 248.
LONG-TERM FOLLOW-UP OF PATIENTS WITH ABSORBABLE STENT IMPLANTATION
DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION – PRAGUE-19 STUDY
P. Toušek, V. Kočka, R. Petr, M. Malý, M. Hajšl, L. Lisa, T. Buděšínský, P. Widimský
(Prague)
14:20 249.
CYSTATIN C IS ASSOCIATED WITH THE EXTENT AND CHARACTERISTICS OF CORONARY
ATHEROSCLEROSIS IN PATIENTS WITH PRESERVED RENAL FUNCTION
A. Král, T. Kovárník, H. Skalicka, J. Horák , K. Bayerová, Z. Vanickova, H. Benáková, A.
Linhart (Prague)
14:30 250.
ABSORBABLE STENTS IN ROUTINE PRACTICE. NEW ERA OF INTERVENTIONAL
CARDIOLOGY
J. Škvařil, M. Malý, M. Černohous, P. Sedloň, M. Hajšl, M. Zavoral (Prague)
14:40 251.
MONITORING OF S100-BETA PROTEIN LEVEL IN PATIENTS UNDERGOING CAROTID
STENTING AND ITS RELATION TO HAEMODYNAMIC AND EMBOLIC PARAMETERS
DETECTED BY TRANSCRANIAL DOPPLER ULTRASONOGRAPHY
M. Špaček, C. Štěchovský, M. Horváth , P. Hájek , P. Zimolová , J. Veselka (Prague)
14:50 252.
DEGENERATIVE CHANGES AND INFLAMMATORY RESPONSE AFTER PERCUTANEOUS
AORTIC VALVE REPLACEMENT IN COMPARISON WITH SURGERY REPLACEMENT
J. Sulženko, P. Toušek , V. Kočka , F. Bednář, H. Línková, R. Petr, M. Laboš, P.
Widimský (Prague)
15:00 253.
COMPARISON OF RADIAL OCCLUSION DETECTION AFTER TRANSRADIAL CORONARY
ANGIOGRAPHY AND INTERNVENTION USING TWO METHODS – REVERSE BARBEAU
AND DUSG
Š. Jirouš, I. Bernat, R. Rokyta (Pilsen)
15:10-16:10
"Hands on"- Left Heart Contrast Echocardiography
Chairpersons: A. Borg, R. Kočková, K. Mědílek (Birkirkara, Malta, Prague, Hradec
Králové)
15:10 254.
BASIC PRINCIPLES AND APPLICATIONS
A. Borg (Birkirkara, Malta)
15:30 255.
...IN PATHOLOGIES OF LEFT HEART
15:50 256.
… IN STRESS ECHOCARDIOGRAPHY
K. Mědílek (Hradec Králové)
16:10
Break
16:20-17:20
What Should a Cardiologist Know About Ventricular Tachycardias (workshop
supported by model case reports)
Chairpersons: J. Kautzner, L. Haman (Prague, Hradec Králové)
16:20 257.
MECHANISMS, DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS
P. Peichl (Prague)
16:35 258.
PATIENT WITH FREQUENT VENTRICULAR ECTOPY
A. Bulava (České Budějovice)
16:50 259.
PATIENT WITH IDIOPATHIC VENTRICULAR TACHYCARDIA
M. Fiala (Třinec)
17:05 260.
PATIENT WITH VENTRICULAR TACHYCARDIA AND STRUCTURAL HEART DISEASE
P. Neužil (Prague)
17:20
End of programme
8:30-9:30
Working Group of Valvular and Congenital Heart Diseases in Adults
How to decide in case of this valvular disease?
Interactive Session with Voting
Chairmans: M. Mates, D. Marek, J. Januška (Prague, Olomouc, Třinec)
8:30
261.
WHY DOES PATIENT WITH HOCM EXPERIENCE DYSPNOEA?
J. Januška (Třinec)
8:45
262.
AORTIC REGURGITATION AND DILATED CARDIOMYOPATHY
9:00
263.
COMBINED AORTIC VALVE DISEASE
K. Linhartová (Pilsen)
9:15
264.
THREE TIMES AND ENOUGH
J. Nečas (Brno)
9:30-10:30
ECG Quiz in Arrhythmology
Chairmans: L. Haman, J. Kautzner, P. Peichl (Hradec Králové, Prague)
9:30
265.
ARRHYTHMIAS I
L. Haman (Hradec Králové)
10:00 266.
ARRHYTHMIAS II
P. Peichl (Prague)
10:30
Break
11:00-12:30
Czech Association of Cardiovascular Imaging
Echocardiography in Aortic Valve Diseases (Niederle’s block)
Chairpersons: H. Skalická, T. Paleček (Prague)
11:00 267.
LOW-GRADIENT AORTIC STENOSIS
K. Linhartová (Prague)
11:15 268.
LEFT VENTRICLE IN AORTIC STENOSIS
E. Mandysová (Prague)
11:30 269.
ROLE OF ECHOCARDIOGRAPHY IN PERCUTANEOUS AORTIC VALVE
IMPLANTATION IN PATIENTS WITH AORTIC STENOSIS
T. Mráz (Prague)
11:45 270.
OPTIMAL QUANTIFICATION OF AORTIC REGURGITATION
Z. Hlubocká (Prague)
12:00 271.
INDICATIONS FOR PROCEDURES ON ASCENDING AORTA
12:15
Discussion
12:30
Lunch break
13:00-14:00
Novartis s.r.o. Symposium
EntrestoTM – NEW CONCEPT IN TREATMENT OF CHRONIC HEART FAILURE WITH
PRESERVED EJECTION FRACTION
Chairperson: R. Pudil (Hradec Králové)
13:00 272.
DIFFERENTIAL DIAGNOSIS IN PATIENTS WITH HEART FAILURE AND REDUCED
EJECTION FRACTION
A. Linhart (Prague)
13:10 273.
IMPORTANCE OF NATRIURETIC PEPTIDES IN CLINICAL PRACTICE
13:20 274.
FUTURE OF HEART FAILURE TREATMENT IN THE LIGHT OF PARADIGM-HF TRIAL
13:35 275.
PANEL DISCUSSION: SILENTLY PROGRESSING PATIENT WITH HEART FAILURE AND
REDUCED EJECTION FRACTIO0N
13:45 276.
PANEL DISCUSSION: PATIENT WITH ADVANCED HEART FAILURE AND MARKED
SYMPTOMATOLOGY
13:55
Discussion
14:00
Break
14:10-15:10
Working Group Kardio 35
Interactive Echo Quiz or ”Interesting Cases from Clinical Practice”
Chairpersons: A. Linhart, R. Kočková (Prague)
14:10 277.
A SERIES OF CASE REPORTS – PART 1
M. Kotrč (Prague)
14:40 278.
A SERIES OF CASE REPORTS – PART 2
J. Marek (Prague)
15:10-16:10
Interactive Case Reports of ECG and Clinical Practice
Chairpersons: J. Vojáček, J. Šimek, T. Janota, T. Hnátek (Hradec Králové, Prague)
16:10
Break
16:20-17:20
Berlin-Chemie/A.Menarini Česká republika s.r.o. Symposium
Are Beta-Blockers Comparable in Treatment of Cardiovascular Diseases?
Chairpersons: L. Špinarová, J. Vítovec (Brno)
16:20 279.
PHARMACOLOGICAL DIFFERENCES BETWEEN BETA-BLOCKERS
J. Vítovec (Brno)
16:40 280.
WHICH BETA-BLOCKERS ARE SUITABLE FOR TREATMENT OF HYPERTENSION?
M. Souček (Brno)
17:00 281.
WHAT CONCLUCIONS HAVE SENIOR STUDY BROUGHT FOR HEART FAILURE ?
17:20
Break
17:30-18:30
CVRx, Inc. Symposium
A New Treatment Option for Patients with Heart Failure and Low Ejection Fraction:
Baroreflex Activation Therapy
Chairpersons: M. Čermáková, M. Táborský (Minneapolis, United States, Olomouc)
18:30
End of programme
POSTER SESSION - DOCTORS (Room E 1st floor, foyer)
10:30-11:00
Moderated Poster Session 1
Moderated discussion will take place from 10.30 to 11.00. Evaluation
commission: M. Želízko, J. Šťásek,
R. Čihák, M. Fiala (Prague, Hradec Králové, Třinec)
282.
ELEVATION OF CARDIAC TROPONIN T IN PATIENTS WITH AMYOTROPHIC LATERAL
SCLEROSIS
L. Mach, T. Konečný, K. Helánová, A. Jaffe, E. Sorenson, V. Somers, G. Reeder (Brno,
Los Angeles, CA, United States, Rochester, MN, United States)
283.
IMPORTANCE OF ECHOCARDIOGRAPHIC AND LABORATORY PARAMETERS FOR
PREDICTING MORTALITY, STROKE EVENTS AND DEVELOPMENT OF PULMONARY
HYPERTENSION IN PATIENTS WITH PULMONARY EMBOLISM
D. Vindiš, M. Hutyra, S. Littnerová, M. Táborský (Olomouc, Brno)
284.
RECURRENCE ANALYSIS IN DETECTION OF AUTONOMIC DYSFUNCTION IN PATIENTS
WITH VASOVAGAL SYNCOPE
L. Riedlbauchová, J. Schlenker, T. Nedělka, V. Socha, A. Schlenkerová, V. Potočková, Š.
Malá, P. Kutílek , J. Veselka (Prague, Kladno)
285.
ELECTRICAL STORM – EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) BRIDGE TO CATHETER ABLATION / BRIDGE TO RECOVERY.
L. Pavlů, M. Lazárová, M. Táborský, J. Petřková (Olomouc)
286.
S100-BETA PROTEIN AS PROGNOSTIC MARKER OF NEUROLOGICAL OUTCOME IN
PATIENTS TREATED WITH MILD THERAPEUTIC HYPOTHERMIA AFTER OUT-OFHOSPITAL CARDIAC ARREST COMPLICATING ACUTE MYOCARDIAL INFARCTION
Š. Hudec, M. Hutyra, J. Přeček, D. Šaňák, M. Král, T. Adam, J. Jarkovský, O. Moravec,
M. Táborský (Olomouc, Brno)
287.
POSSIBLE CAUSES OF DISCREPANCY BETWEEN FRACTIONAL FLOW RESERVE OF
CORONARY BED AND NON-HYPERAEMIC INDEX iFR
Š. Jeřábek, T. Kovárník, A. Král, H. Skalická, A. Linhart (Prague)
288.
CORONARY ARTERY FISTULAS
O. Aschermann, M. Mates, P. Kmoníček, P. Formánek, K. Kopřiva (Prague)
289.
THROMBOSES OF LEFT ATRIAL APPENDAGE OCCLUDERS
P. Hála, L. Dujka, M. Chovanec, M. Janotka, T. Mráz, J. Petrů, M. Prokopová, L. Šedivá,
J. Škoda, P. Neužil (Prague)
290.
OCT VOLUMETRY OF INTIMAL HYPERPLASY OF RADIAL ARTERY AFTER PCI
T. Nováková, J. Kaňovský, R. Miklík, L. Přívarová, M. Poloczek, O. Boček, P. Jeřábek, J.
Jarkovský, P. Kala (Brno)
291.
INFLAMMATORY RESPONSE AFTER IMPLANTATION OF SECOND GENERATION
ABSORBABLE AND DRUG-ELUTING STENTS IN STABLE CAD
V. Novotný, I. Varvařovský, J. Matějka, V. Rozsíval, T. Lazarák, P. Vojtíšek (Pardubice)
292.
TRANSCATHETER LEFT ATRIAL APPENDAGE CLOSURE IN OUR DEPARTMENT
L. Vlažná, J. Jakabčin, P. Červinka (Ústí nad Labem)
8:00-18:00
293.
Poster Session 1
POST-MYOCARDIAL INFARCTION VENTRICULAR SEPTAL DEFECT CASE REPORT
D. Matouš (Třinec)
294.
BRUGADA SYNDROME - CASE REPORT, RISK STRATIFICATION AND TREATMENT
M. Derevjaník (Prague)
295.
SUBEPICARDIAL HAEMATOMA AS RARE COMPLICATION OF CORONARY
ANGIOGRAPHY
J. Mikovčák, J. Fismol, M. Branny (Třinec)
296.
DEEP VENOUS THROMBOSIS IN YOUNG WOMAN WITH MAY-THURNER SYNDROME
COMPLICATED BY PULMONARY EMBOLISM. CASE REPORT
Z. Jadvišová, F. Roháč, B. Kožnar (Prague)
297.
PATIENT AFTER PROCEDURE ON ABDOMINAL AORTA
R. Kološová, D. Kučera, M. Válka, K. Zeman, I. Pavlas, T. Gistinger (Frýdek-Místek,
Ostrava)
298.
COMPLICATIONS OF PERMANENT CARDIAC PACING – ONE CASE FOR ALL
V. Černíček, E. Pospíšilová, V. Gloger (Zlín)
299.
ACUTE CORONARY SYNDROME IN YOUNG PROFESSIONAL ATHLETE IMMEDIATELY
AFTER EXTREME PHYSICAL PERFORMANCE – CASE REPORT
P. Grossmannová, V. Kaučák, K. Novobílský, R. Kryza, P. Černý (Ostrava)
300.
SEEMINGLY FOREIGN BODY IN LEFT ATRIUM AFTER CATHETER ABLATION OF
PERSISTENT ATRIAL FIBRILLATION
T. Skála, M. Hutyra, O. Moravec, Z. Tudos, M. Táborský (Olomouc)
301.
LEFT ATRIAL MYXOMA – SILENTLY, ACROSS HEART
B. Holek, M. Urban, M. Branny (Třinec)
302.
RELATIONSHIP BETWEEN BIOMARKERS OF OXIDATIVE STRESS AND ATRIAL
FIBRILLATION IN PATIENTS UNDERGOING RADIOFREQUENCY ABLATION
A. Bohm, L. Tothova, L. Urban, P. Slezak, L. Bacharova, P. Musil, R. Hatala (Bratislava,
SR)
303.
CLINICAL APPLICATION OF TELEMEDICINE
P. Rohánek (Olomouc)
304.
COMPARISON OF RADIATION EXPOSURE, CONTRAST AGENT AMOUNT AND COSTEFFECTIVENESS OF IMAGING METHODS 3DRA AND CT OF LEFT ATRIUM USED IN
SUPPORT OF CATHETER ABLATION IN LEFT ATRIUM
J. Jež, Z. Stárek, F. Lehar, J. Wolf, T. Kulík , A. Žbánková, M. Novák (Brno)
305.
IMPLANTATION OF REMODULIN INFUSION PUMP – NEW TREATMENT OPTION FOR
PULMONARY ARTERIAL HYPERTENSION
D. Klimeš, D. Hetclová, H. Grofková (Olomouc)
306.
MYOCARDIAL RUPTURE IN TAKOTSUBO CARDIOMYOPATHY – CASE REPORT
J. Hůlka, M. Solař, J. Soukup (Hradec Králové)
307.
PROGNOSTIC SIGNIFICANCE OF TROPONIN T ASSESSMENT BY HIGH-SENSITIVE
METHOD IN PATIENTS WITH CHEST PAIN AND DYSPNEA OF NON-CARDIAC
AETIOLOGY IN ACUTE MANAGEMENT
F. Varhaník, R. Pudil, I. Karešová, P. Bartoň, V. Palička (Hradec Králové)
308.
CONGENITAL ANOMALY OF INFERIOR VENA CAVA COMPLICATING RADIOFREQUENCY
ABLATION – CASE REPORT
O. Moravec (Olomouc)
309.
BRUGADA SYNDROME OR BRUGADA PHENOCOPY?
DYNAMICS OF ECG CHANGES DURING ADDISONIAN CRISIS IN PATIENT WITH
HISTORY OF BRUGADA SYNDROME
V. Pavliňák, J. Kuchař, D. Rob, M. Chochola, P. Vařejka, J. Lubanda, A. Linhart (Prague)
310.
CIRCADIAN VARIABILITY IN DEVELOPMENT OF ACUTE HEART FAILURE
M. Pavlušová, M. Pávková - Goldbergová , J. Svoboda, S. Littnerová , M. Felšöci, P.
Lokaj, E. Ganovská, J. Špinar, J. Pařenica (Brno)
311.
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR: GOOD SERVANT BUT SOMETIMES
BAD MASTER 2
J. Pindor, M. Branny, R. Neuwirth, O. Jiravský, D. Wojnarová, J. Gorzolka, D. Vavřík, Š.
Krawiec (Třinec)
312.
SIX YEARS OF COAGULATION CLINIC PRACTIE OR WHERE WE ARE HEADING IN THE
AGE OF NEW ANTICOAGULANTS
J. Matoušková, Z. Minariková, P. Hála, P. Neužil, J. Balázs (Prague)
313.
TAKO-TSUBO CARDIOMYOPATHY IN A FEMALE PATIENT WITH ESSENTIAL
THROMBOCYTHEMIA TREATED WITH ANAGRELIDE
L. Eremiášová, J. Marek, A. Král, T. Paleček, M. Aschermann, A. Linhart, V. Danzig
(Prague)
314.
OUR EXPERIENCE WITH ROTABLATION IN REGIONAL HOSPITAL LIBEREC
A. Afxentiou, D. Horák , V. Hraboš, Z. Šembera (Liberec)
315.
TRANSCATHETER TREATMENT OF COMPLICATION AFTER CARDIAC SURGERY –
MITRAL VALVE ANNULOPLASTY - DISRUPTION OF THE SUTURE OF THE POSTERIOR
ANNULUS WITH SIGNIFICANT PARAVALVULAR LEAK, TRANSCATHETER LEAK CLOSURE
BY TRANSSEPTAL APPROACH – CASE REPORT
G. Mairgani, M. Mates, M. Prokopová, J. Matoušková (Teplice, Prague)
316.
CONSERVATIVE TREATMENT OF PROSTHETIC VALVE INFECTIVE ENDOCARDITIS
L. Tauchenová, M. Bláha, J. Vrbská, J. Kautzner (Prague)
317.
ANALYSIS OF PATIENTS WITH IMPLANTED PACEMAKER IN CARDIAC PACING CENTRE
IN FRYDEK-MISTEK IN 2015
T. Gistinger, K. Zeman, I. Pavlas (Frýdek-Místek)
318.
UNUSUAL COMPLICATION OF TRANSOESOPHAGEAL ECHOCARDIOGRAPHY
K. Kubišová, M. Dorda, M. Branny (Třinec)
319.
RIGHT VENTRICULAR ELECTRODE DISLOCATION WITH INADEQUATE RESPONSE OF BIV
ICD
K. Kubišová, O. Jiravský, M. Branny (Třinec)
320.
BIORESORBABLE STENTS – 2-YEAR RESULTS OF CLINICAL AND ECHOCARDIOGRAPHIC
FOLLOW-UP
P. Hájek, M. Horváth, C. Štěchovský, R. Adlová, P. Tomašov, J. Veselka (Prague)
321.
TIMING CYCLES OF CARDIAC RESYNCHRONIZATION DEVICES WITH LEFT
VENTRICULAR SENSING OPTIONS – CASE REPORT
K. Hlavatá, M. Tanzerová, K. Sedláček, P. Řezáč, J. Kautzner (Prague)
322.
CAN WE USE BIOMARKERS IN THE DIAGNOSIS OF ACUTE MYOCARDITIS MIMICKING
ACUTE CORONARY SYNDROME?
E. Ganovská, S. Littnerová, P. Kubena, M. Pavlušová, J. Jarkovský, J. Špinár, J. Pařenica
(Brno)
323.
IMPLANTABLE ECG RECORDER REVEAL LINQ – COMPARISON WITH PREVIOUS
GENERATION AND
H. Mudrochová, M. Mudroch, L. Šedivá, J. Petrů, P. Neužil (Prague)
324.
PSEUDOANEURYSM OF THE ASCENDING AORTA AFTER BENTALL SURGERY FOR
ACUTE AORTIC DISSECTION TYPE A
L. Gajdušek, B. Holek, M. Pleva (Třinec)
325.
DAMAGED PACING LEAD – CONSEQUENCE OF A CLAVICLE FRACTURE
J. Pindor, J. Gorzolka, D. Vavřík, O. Jiravský, D. Wojnarová, M. Branny (Třinec)
326.
LEPTIN AS A PREDICTOR OF ATRIAL FIBRILLATION RECURRENCE IN PATIENTS TREATED
BY RADIOFREQUENCY ABLATION
F. Souček (Brno)
327.
UNEXPECTED CAUSE OF SYNCOPE
P. Novotný, R. Panovský, M. Novák, V. Feitová, L. Špinarová (Brno)
328.
COMPARISON OF ATRIAL FIBRILLATION ABLATION PARAMETERS WHEN USING
COOLED CATHETER WITH FUNCTION OF CONTACT FORCE MEASUREMENT AND
STANDARD COOLED-TIP CATHETER
F. Lehar, Z. Stárek, J. Jež, Z. Svanovská, J. Wolf, T. Kulík , A. Žbánková (Brno)
329.
ROTABLATION – FIRST EXPERIENCE IN OUR DEPARTMENT
J. Mrózek, L. Pleva, M. Porzer, R. Nykl, P. Kukla, P. Berger, M. Homza (Ostrava)
330.
STENOSIS OF THE PULMONARY VEINS AFTER SURGICAL MAZE PROCEDURE
K. Kubišová, L. Škňouřil, M. Branny (Třinec)
331.
HYPERTENSION IN THE ELDERLY AND ITS TREATMENT AT CLINIC OF INTERNAL
MEDICINE – CARDIOLOGY, THE UNIVERSITY HOSPITAL BRNO BOHNICE
M. Holická, J. Špinar (Brno)
332.
PRESENTATION OF INTRAVASCULAR IMAGING RECORDS USING OPTICAL
COHERENCE TOMOGRAPHY (OCT) FOCUSED ON LATEST GENERATION OF
BIODEGRADABLE INTRACORONARY STENTS (BVS)
O. Boček, P. Jeřábek, M. Poloczek, R. Miklík, J. Kaňovský, R. Štípal, P. Kala (Brno)
333.
SIMULTANEOUS CARDIOEMBOLIC MYOCARDIAL INFARCTION AND STROKE TREATED
BY TROMBOASPIRATION FROM ATYPICALLY ORIGINATING CORONARY ARTERY AND
SUBSEQUENT THROMBOLYSIS
Z. Coufal, V. Černíček, P. Kopřiva (Zlín)
334.
LEFT ATRIAL MYXOMA IN A FEMALE PATIENT AFTER STROKE
J. Látal, K. Vykoupil, M. Fedorco, M. Hutyra, P. Heinc, M. Táborský (Olomouc)
335.
TRANSRADIAL PCI OF SUBTOTAL BIFURCATION RIA-RD STENOSIS USING TWO
BIORESORBABLE SCAFFOLDS ABSORB
Z. Coufal, P. Kopřiva (Zlín)
336.
SECONDARY PROLOGED QT INTERVAL IN OSTEOMALACIA
J. Galuszka, M. Táborský (Olomouc)
337.
TREATMENT OF SUBMASSIVE PULMONARY EMBOLISM IN THE UNIVERSITY HOSPITAL
BRNO
J. Hlásenský, O. Ludka, J. Špinar (Brno)
338.
MAGNETIC RESONANCE IMAGING IN PATIENTS WITH IMPLANTED ICD OR
PERMANENT PACEMAKER
M. Chovanec, M. Janotka, L. Šedivá, J. Šimon, J. Škoda, J. Petrů, P. Neužil (Prague)
339.
TYPE A AORTIC DISSECTION MANIFESTING AS 2 STEMI
R. Surovčík, A. Kupec, P. Červinka, K. Jirásek (Prague, Ústí nad Labem)
340.
OPTIONS OF MICRORNA USE IN THE EARLY DIAGNOSIS OF ACUTE
MYOCARDIAL INFARCTION
V. Biel, J. Novák, O. Hlinomaz, L. Špinarová (Brno)
341.
ERECTILE DYSFUNCTION TREATMENT IN USUAL PRACTICE
V. Adámková (Prague)
342.
INTERNAL CAROTID ARTERY ANEURYSM AS UNUSUAL MANIFESTATION OF MARFAN
SYNDROME
L. Koc, T. Zatočil, T. Brychta, A. Nečasová, J. Špinar (Brno)
343.
RESPIRATORY REFLEXES AND POSSIBILITIES OF THEIR USE IN ORDER TO PREVENT
DEVELOPMENT OF VASOVAGAL SYNCOPE
M. Bavolárová, E. Szabóová, Z. Tomori, A. Brandenburová, V. Donič, S. Palko (Košice,
SR)
344.
ATRIAL FIBRILLATION RECURRENCE IN PATIENTS AFTER NON-PHARMACOLOGICAL
TREATMENT – OUR EXPERIENCE WITH TREATMENT
M. Chovanec, M. Janotka, L. Šedivá, J. Škoda, J. Petrů, P. Neužil (Prague)
345.
HOSPITAL MANAGEMENT OF PATIENTS WITH CARDIAC ARREST IN THE
REGIONAL HOSPITAL KARLOVY VARY. THREE-YEAR EXPERIENCE WITH MANAGEMENT
OF EMERGENCY AND JOINT INTENSIVE CARE BED FUND
A. Schee, D. Märzová, M. Štroffeková, Z. Kos, Z. Peroutka, R. Janda, M. Paďour
(Karlovy Vary)
POSTER SESSION – HEALTH CARE WORKERS (Room A3)
8:00-18:00
346.
Poster Session – Health Care Workers
EXPIRATORY MUSCLE TRAINING WITH THRESHOLD PEP® AID IN
CHRONIC HEART FAILURE – EXEMPLARY CASE REPORT
F. Dosbaba, P. Žurková, L. Baťalík, R. Vysoký, O. Ludka, J. Špinar (Brno)
347.
CASE REPORT OF PATIENT WITH BIVENTRICULAR ICD AND INFECTIVE ENDOCARDITIS
IN UNUSUAL LOCATION
O. Jedličková, I. Humlová, I. Mertová, J. Strnadová, M. Prokopová, T. Mráz (Prague)
348.
USE OF NIV IN CARDIOLOGY
K. Čechotová, E. Pospíšilová (Prague)
349.
USE OF SIX-MINUTE WALK TEST IN HEART FAILURE CLINIC
H. Rakovská, I. Továrková , M. Lazárová (Olomouc)
350.
USE OF COMPRESSION STOCKINGS IN CLINICAL PRACTICE
I. Ošťádalová, M. Kaletová (Olomouc)
351.
SCREENING FOR OBSTRUCTIVE SLEEP APNEA IN PATIENT WITH ARTERIAL
HYPERTENSION USING APNEA-LINK
I. Buriánková, P. Doupalová, I. Benušová (Olomouc)
352.
PRINCIPLES OF HOME BLOOD PRESSURE MEASUREMENT
P. Doupalová, I. Benušová, I. Buriánková (Olomouc)
353.
ASSESSEMENT OF ANTIHYPERTENSIVE DRUG LEVELS IN PATIENTS WITH RESISTANT
HYPERTENSION
I. Benušová, P. Doupalová, I. Buriánková (Olomouc)
354.
BRUGADA SYNDROME OR NURSES‘ KNOWLEDGE OF ECG
M. Navrátilová, J. Malík, T. Janota (Prague)
355.
ULTRASOUND GUIDED PUNCTURE OF FEMORAL BLOOD-VESSELS DURING CATHETER
ABLATION OF ARRHYTHMIAS
K. Opachová, O. Jiravský, R. Rusnoková, J. Franková, D. Wojnarová, N. Rotter, M.
Sikorová, R. Zoubková (Třinec)
356.
CARDIAC SYNDROME X
I. Mejtská, M. Frantlová, Z. Pospíšilová, E. Sovová (Olomouc)
357.
VYTRONUS – LOW-INTENSITY ULTRASOUND ABLATION SYSTEM
K. Holdová, Š. Královec (Prague)
358.
MYOCARDIAL PERFUSION SCINTIGRAPHY USING THALLIUM-201
I. Křivánková, M. Velichová (Brno)
359.
DEPARTMENT OF NUCLEAR CARDIOLOGY, THE INTERNATIONAL CLINICAL RESEARCH
CENTER OF ST. ANNE’S UNIVERSITY HOSPITAL BRNO
M. Velichová, I. Křivánková (Brno)
360.
USE OF VASCULAR PROBE IN CATHETERIZATION - INITIAL
EXPERIENCE
P. Konečný, P. Peichl (Prague)
361.
FIRST EXPERIENCE WITH CATHETER ABLATION OF ATRIAL FIBRILLATION SUPPORTED
BY CONTACT FORCE TECHNOLOGY TACTICATH QUARTZ
Z. Svánovská, Z. Stárek, F. Lehar, J. Jež, J. Wolf, T. Kulík, A. Žbánková (Brno)
362.
IMPLANTATION OF SUBCUTANEOUS ICD
M. Šebestová, A. Slížková , V. Vejvoda, V. Vančura (Pilsen)
363.
INFECTIVE ENDOCARDITIS AS A CONSEQUENCE OF INTRAMUSCULAR INJECTION CASE REPORT
J. Pazderová (Olomouc)
364.
USE OF STANDARDIZED CARE PLANS IN CLINICAL PRACTICE
M. Šenkyříková (Brno)
365.
RELATIONSHIP BETWEEN LEFT ATRIAL SIZE ASSESSED BY CT AND BY
ELECTROANATOMIC MAPPING
Z. Fingrová, Š. Havránek, J. Marek, L. Lambert, J. Šimek, D. Wichterle, A. Linhart
(Prague)
Tuesday 17 May 2016
ROTUNDA (Room A)
8:00-9:30
The Best of Czech Cardiology
Chairpersons: P. Widimský, M. Táborský (Prague, Olomouc)
8:00
366.
Direct Catheter-Based Thrombectomy for Acute Ischemic Stroke: Outcomes of
Consecutive Patients Treated in Interventional Cardiology Centers in Close
Cooperation With Neurologists
P. Widimský, T. Asil, M. Abelson, B. Kožnar, A. Tasal, J. Roos, P. Vasko, T. Peisker, C.
Deniz, J. Vavrová (Prague, Istanbul, Turkey, Cape Town, South Africa, Stockholm,
Sweden, Kronoberg, Sweden)
8:09
367.
Randomized comparison of renal denervation versus intensified pharmacotherapy
including spironolactone in true-resistant hypertension: six-month results from the
Prague-15 study.
J. Rosa, P. Widimský, P. Toušek, O. Petrák, K. Čurila, P. Waldauf, T. Zelinka, R. Holaj,
M. Táborský, J. Widimský jr. (Prague, Olomouc)
8:18
368.
One-Year Clinical and Computed Tomography Angiographic Outcomes After
Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary
Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study
R. Petr, P. Widimský, P. Toušek, M. Malý, H. Línková, J. Vrána, M. Hajšl, T. Buděšínský,
L. Lisa, V. Kočka (Prague)
8:27
369.
Left Ventricular Lead Electrical Delay Is a Predictor of Mortality in Patients With
Cardiac Resynchronization Therapy
T. Roubíček, D. Wichterle, P. Kučera, P. Nedbal, J. Kupec, J. Sedláková, J. Černý, J.
Štros, J. Kautzner, R. Polášek (Liberec, Prague)
8:36
370.
Impact of urgent coronary angiography on mid-term clinical outcome of comatose
out-of-hospital cardiac arrest survivors presenting without ST-segment elevation.
M. Kleissner, M. Šramko, J. Kohoutek, J. Kautzner, J. Kettner (Prague)
8:45
371.
Transatlantic differences in assessment of risk of sudden cardiac death in patients
with hypertrophic cardiomyopathy
D. Jahnlová, P. Tomašov, D. Zemánek, J. Veselka (Prague)
8:54
372.
Clinical Outcome of Transcatheter Treatment of Heart Failure with Preserved or
Mildly Reduced Ejection Fraction using a Novel Implant.
F. Málek, P. Neužil, F. Gustafsson, D. Kaye, A. Walton, M. Mates, L. Sündergaard, N.
Ihlemann, J. Mariani, V. Reddy (Prague, Copenhagen, Denmark, Melbourne, Australia,
New York, United States)
9:03
373.
Serum Dickkopf-1 signaling and calcium deposition in aortic valve are significantly
related to the presence of concomitant coronary atherosclerosis in patients with
symptomatic calcified aortic stenosis
Z. Moťovská, T. Vichová, M. Doktorová-Sionová, M. Laboš, M. Malý, P. Widimský
(Prague)
9:12
374.
Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Predict Mortality in Adults
With Congenital Heart Disease
J. Popelová, K. Kotaška, M. Tomková, J. Tomek (Prague)
9:21
375.
Bioptic Study of Left and Right Atrial Interstitium in Cardiac Patients with and without
Atrial Fibrillation: Interatrial but Not Rhythm-Based Differences
M. Bláha, N. Smorodinova, L. Lantová, V. Melenovský, J. Hanzelka, J. Pirk, J. Kautzner,
T. Kučera (Prague)
9:30-10:30
Czech Society for Hypertension
Unconventional Antihypertensive Drugs
Chairpersons: R. Cífková, V. Monhart (Prague)
9:30
376.
IS SPIRONOLACTONE THE MOST EFFECTIVE ANTIHYPERTENSIVE DRUG?
9:45
9:50
Discussion
377.
EPLERENONE IN HYPERTENSION TREATMENT
J. Vítovec (Brno)
10:05
Discussion
10:10 378.
AND WHAT ABOUT AMILORIDE?
H. Rosolová (Pilsen)
10:25
Discussion
10:30
Break
11:00-12:30
Slovak Society of Cardiology
Real Clinical Practice from Tatras to Danube (with Message up to Šumava?)
Cardiovascular Epidemies in the Light of Thousand-Registries
Chairpersons: A. Linhart, P. Hlivák (Prague, Bratislava, SR)
11:00 379.
LESSONS FROM HEART FAILURE REGISTRIES IN SLOVAKIA
E. Goncalvesová (Bratislava, SR)
11:20 380.
SAFIS – WHAT DO WE KNOW ABOUT ATRIAL FIBRILLATION IN THE ELDERLY?
M. Dúbrava, T. Drobná, F. Németh, L. Gerlich (Bratislava, SR, Trenčín, SR, Prešov, SR,
Bojnice, SR)
11:40 381.
REALFIB – REAL EFFICACY OF STROKE PREVENTION IN ATRIAL FIBRILLATION
P. Hlivák, Ľ. Paulis, K. Chroust, R. Hatala (Bratislava, SR, Brno)
12:00 382.
DISCUSSION: WHAT TO DO WITH REGISTRIES?
12:30
Lunch break
13:00-14:00
Rivaroxaban Treatment Strategy in Unusual Situations
Chairpersons: P. Dulíček, S. Penka, J. Chlumský, D. Karetová (Hradec Králové, Brno,
Prague)
14:00
Break
14:10-15:10
Non-ST Elevation Acute Coronary Syndromes – What Are the News in 2016?
Chairpersons: Z. Moťovská, J. Vojáček (Prague, Hradec Králové)
14:10 383.
DIAGNOSTIC ALGORITHM
T. Janota (Prague)
14:22 384.
TIMING OF CORONARY ANGIOGRAPHY
14:34 385.
ANTITHROMBOTIC THERAPY
14:46 386.
SOLVING BLEEDING COMPLICATIONS
R. Rokyta (Pilsen)
15:10
Break
15:15-16:15
Czech Society for Atherosclerosis
Problems of Hypolipidemic Treatment in Patients with CAD and Their Solutions.
Chairpersons: H. Vaverková, M. Vrablík (Olomouc, Prague)
15:15 387.
PATIENT WITH CAD DOES NOT WANT TO OR CANNOT TAKE STATIN
J. Piťha (Prague)
15:35 388.
PATIENT WITH CAD WANTS TO AND CAN TAKE STATIN BUT IT IS NOT ENOUGH
V. Bláha (Hradec Králové)
15:55 389.
STATINS AND DIABETES MELLITUS – OVERESTIMATED RISK
V. Soška, O. Kyselák (Brno)
16:15
Break
16:20-17:30
Free Lectures - Emergencies in Cardiology, Arrhythmias
Chairpersons: J. Kautzner, A. Krüger (Prague)
16:20 390.
THIRD-DEGREE ATRIOVENTRICULAR BLOCK IN 50-YEAR-OLD WOMAN – CASE
REPORT
K. Zeman, J. Chovančík, T. Gistinger, V. Mrózek, I. Pavlas, R. Kološová, M. Tropp, M.
Pleva (Frýdek-Místek, Třinec)
16:30 391.
CLINICAL SIGNIFICANCE OF LEFT ATRIAL APPENDAGE RESECTION IN THE SURGICAL
ABLATION OF ATRIAL FIBRILLATION
V. Kurfirst, B. Kuta, J. Čanádyová, A. Mokráček (České Budějovice)
16:40 392.
NEW-ONSET HEART FAILURE IN ATRIAL FIBRILLATION AND ACUTE LIVER FAILURE
AFTER ADMINISTRATION OFAMIODARONE
M. Bláha, J. Vrbská, J. Kautzner (Prague)
16:50 393.
EXTRACORPOREAL RESUSCITATION (ECLS) IN CIRCULATORY ARREST – EARLY
MORTALITY PREDICTION OPTIONS
A. Krüger, P. Ošťádal, M. Janotka, D. Vondráková, I. Skalský, P. Neužil (Prague)
17:00 394.
CLINICAL MANIFESTATIONS OF PAROXYSMAL HYPERTENSION IN PRACTICE
J. Václavík, A. Křenková, E. Kociánová, T. Václavík, M. Kamasová (Olomouc, Prague)
17:10 395.
CHANGES OF BRAIN TISSUE OXYGENATION IN PATIENTS WITH CHRONIC RENAL
FAILURE
J. Malík, J. Kudlička, J. Lachmanová, A. Valeriánová (Prague)
17:20 396.
TROPONIN I – WHAT LEVEL IS “NORMAL” ?
T. Hnátek, J. Daněk, M. Táborský , M. Malý, L. Kameník, P. Sedloň, J. Luxová, M.
Fišerová, Š. Hamouzová, M. Zavoral (Prague, Olomouc)
17:30
End of programme
MORAVA (Room A3)
8:30-9:30
Free Lectures - Technicians
Chairpersons: M. Mudroch, P. Leinveber (Prague, Brno)
8:30
397.
ASSESSMENT OF DISTRIBUTION OF LEFT VENTRICULAR ELECTRICAL
DEPOLARIZATION FROM THORACIC ECG LEADS USING A HIGH FREQUENCY ECG
P. Leinveber, J. Meluzín, P. Jurák, J. Halámek, T. Postránecká, F. Plešinger, J.
Lipoldová, M. Novák (Brno)
8:40
398.
FIRST EXPERIENCE WITH RHYTHMIA MAPPING SYSTEM
M. Mudroch, J. Baroch, M. Mráček, Š. Královec, J. Petrů, J. Škoda, L. Šedivá, P. Neužil
(Prague)
8:50
399.
COOPERATION OF TELEMEDICINE CENTRE WITH CARDIOLOGY OUTPATIENT CLINIC CASE REPORT
V. Michalčinová, V. Bulková, J. Gandalovičová, J. Brada, D. Kovaříková, Š. Sobotková,
L. Ondrášková, A. Polednová, D. Kvasničková, M. Fiala (Považská Bystrica, SR, Brno,
Prague, Třinec)
9:00
400.
DOES QUICKOPT ALGORITHM FAIL IN REDUCTION OF QRS COMPLEX DURATION IN
PATIENTS WITH CARDIAC RESYNCHRONIZATION THERAPY?
H. Jansová, D. Wichterle, R. Polášek, K. Sedláček, J. Kautzner (Prague, Liberec)
9:10
401.
BENEFITS AND LIMITATIONS OF REMOTE MONITORING OF IMPLANTABLE
CARDIOVERTER DEFIBRILLATOR (ICD) IN CLINICAL PRACTICE
L. Nečasová, M. Bláhová, M. Tanzerová (Prague)
9:20
402.
MINIMISING OF PATIENT RADIATION DOSE DURING CT OF LEFT ATRIUM USED TO
SUPPORT CATHETER ABLATION OF COMPLEX ARRHYTHMIAS, PILOT STUDY
J. Wolf, Z. Stárek, J. Jež, F. Lehar, A. Novák, T. Kulík, A. Žbánková, Z. Svánovská, P.
Ouředníček (Brno)
9:30-10:30
Chairpersons: M. Fiala, L. Křivan (Třinec, Brno)
9:30
403.
NON-INDUCIBILITY OF ARRHYTHMIA AS ENDPOINT OF FIRST ABLATION FOR
PAROXYSMAL ATRIAL FIBRILLATION IS RELATED TO LOWER NUMBER OF
ARRHYTHMIA RECURRENCES – RETROSPECTIVE ANALYSIS OF 943 PATIENTS
M. Fiala, L. Rybka, L. Škňouřil, J. Chovančík, R. Neuwirth, O. Jiravský, J. Januška, O.
Toman, J. Špinar (Třinec, Brno)
9:40
404.
OUR EXPERIENCE WITH SUBCUTANEOUS ICD (S-ICD)
J. Šimon, E. Kronusová, J. Petrů, P. Neužil (Prague)
9:50
405.
PACEMAKER AND DEFIBRILLATOR LEADS DISLOCATION – DEFINITION, CAUSES,
CLASSIFICATION, ARRENGEMENTS TO REDUCE OCCURRENCE
P. Bradáč, M. Fedorco (Olomouc)
10:00 406.
CHANGES (NOT ONLY) OF ANTICOAGULATION STRATEGY IN HYBRID
ABLATION OF ISOLATED ATRIAL FIBRILLATION DUE TO THE PRESENCE OF THROMBUS
IN THE LEFT ATRIAL APPENDAGE AFTER SURGICAL PART OF ABLATION
P. Budera, P. Osmančík, R. Fojt, Z. Straka (Prague)
10:10 407.
HYBRID THERAPY OF ISOLATED PERSISTENT AND LONG-STANDING
PERSISTENT ATRIAL FIBRILLATION – PROJECT ENDOMAZE HYBRID, LONG-TERM
RESULTS
P. Budera, P. Osmančík, D. Talavera, Z. Straka (Prague)
10:20 408.
ULTRASOUND-GUIDED PUNCTURE OF FEMORAL BLOOD-VESSELS DURING CATHETER
ABLATION FOR ARRHYTHMIAS
O. Jiravský, M. Branny (Třinec)
10:30
Break
11:00-12:30
Acute Heart Failure
In Cooperation with Czech Association of Acute Cardiology
Chairpersons: R. Rokyta, P. Ošťádal (Pilsen, Prague)
11:00 409.
CLASSIFICATION, EPIDEMIOLOGY
J. Pařenica (Brno)
11:15 410.
DIAGNOSIS AND MONITORING
M. Hromádka (Pilsen)
11:30 411.
LATEST NEWS IN PHARMACOTHERAPY
J. Špinar (Brno)
11:45 412.
VENTILATORY SUPPORT
A. Kruger (Prague)
12:00 413.
CIRCULATORY SUPPORT
12:15
Discussion
12:30
Lunch break
13:00-14:00
Working Group of Cardiology Nurses and Allied Professions
Research in Cardiovascular Nursing
Chairpersons: J. Callerová, D. Křivská, L. Klemsová (Beroun, Prague, Ostrava)
13:00 414.
ULTRASOUND-GUIDED PERIPHERAL VENOUS CANNULATION
J. Callerová, R. Škulec, K. Kučera, J. Knor (Beroun)
13:10 415.
WHO IS WITHOUT SIN CAST THE FIRST STONE OR IS IT POSSIBLE TO
AVERT A MISTAKE
M. Podolská, M. Ludvíková (Prague)
13:20 416.
PERIPARTUM CARDIOMYOPATHY FROM NURSING POINT OF VIEW
H. Lukšová, Y. Vrublová (Ostrava)
13:30 417.
CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE IN CHILDREN WITH
CONGENITAL HEART DISEASE
O. Spurná, P. Kubuš, J. Hojerová, S. Dvořáková (Prague)
13:40 418.
MYOCARDIAL INFARCTION – RISK OF WORKING AGE, NURSING RESEARCH FOR
PRACTICE
R. Pojezdalová, V. Elišerová (Ostrava)
13:50 419.
EFFECT OF CIRCADIAN CHRONOTYPE AND SLEEP OF INTERNAL MEDICINE NURSES
IN SHIFT WORK
L. Šikorská (Olomouc)
14:00
Break
14:10-15:10
Working Group of Paediatric Cardiology
Heart Failure in Childhood
In Cooperation with Czech Association of Heart Failure
Chairpersons: J. Janoušek, J. Špinar (Prague, Brno)
14:10 420.
PATHOPHYSIOLOGY AND BASICS OF PHARMACOTHERAPY IN HEART FAILURE
J. Špinar (Brno)
14:25 421.
ECHOCARDIOGRAPHIC DIAGNOSIS OF HEART FAILURE
V. Tomek (Prague)
14:40 422.
RIGHT VENTRICULAR FAILURE
J. Marek (London, United Kingdom)
14:55 423.
MECHANICAL CIRCULATORY SUPPORT AND HEART TRANSPLANTATION IN
CHILDHOOD
F. Kučera (London, United Kingdom)
15:10
Break
15:15-16:15
Working Group of Paediatric Cardiology
Prenatal Cardiology
Chairpersons: H. Jičínská, J. Marek (Brno, London, United Kingdom)
15:15 424.
ROLE OF PRENATAL ULTRASOUND DIAGNOSIS IN CURRENT CARE OF PREGNANT
WOMEN AND FOETUS
P. Calda (Prague)
15:30 425.
IS IT TIME TO CHANGE MANAGEMENT OF PRENATAL CARDIOLOGY IN FETAL CARE?
H. Jičínská (Brno)
15:45 426.
HEART DISEASES PRENATALLY: DOES IT ALL END FA(E)TALLY?
V. Tomek (Prague)
16:00 427.
ROLE OF GENETICIST IN PRE- AND POST-CONCEPTION CARE
I. Grochová (Brno)
16:15
Break
16:20-17:20
Free Lectures - Hypertension
Chairpersons: P. Neužil, M. Kamasová (Prague, Olomouc)
16:20 428.
SIDE EFFECTS OF SPIRONOLACTONE IN LONG-TERM TREATMENT OF RESISTANT
HYPERTENSION
J. Václavík, D. Tavačová, E. Kociánová, M. Kamasová, M. Václavíková (Olomouc,
Přerov)
16:30 429.
OUTPATIENT SCREENING FOR OBSTRUCTIVE SLEEP APNEA IN PATIENT WITH
RESISTANT ARTERIAL HYPERTENSION USING NIGHT MONITORING BY APNEA-LINK
M. Kamasová, J. Václavík, T. Václavík, M. Hobzová, E. Kociánová (Olomouc, Prague)
16:40 430.
EXTRACORPOREAL NON-INVASIVE ULTRASOUND MEDIATED RENAL SYMPATHETIC
DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION
P. Neužil, Z. Stárek, J. Jež, F. Málek, D. Vondráková, A. Kučerová, S. Michálková, M.
Janotka (Prague)
16:50 431.
HOW FREQUENT IS AMLODIPINE OVERDOSE IN TREATMENT OF ARTERIAL
HYPERTENSION?
E. Kociánová, J. Václavík, H. Janečková, D. Friedecký, M. Kamasová, M. Táborský
(Olomouc)
17:00 432.
TREATMENT OF HYPERTENSION IN PREGNANCY: A SINGLE-CENTER 4-YEAR
RETROSPECTIVE STUDY
V. Pokorná, T. Pázmanová, J. Kalužay, S. Bodíková, P. Ponťuch (Bratislava, SR,
Bratislava)
17:10 433.
COMPARISON OF SAFETY AND EFFICACY OF CATHETER-BASED RENAL DENERVATION
USING DIFFERENT TECHNOLOGIES IN ANIMAL MODEL
M. Táborský, Z. Tonar, D. Richter, A. Herman, L. Červenka, L. Kopkan, J. Peregrin, Z.
Šimůnková, I. Mrázová (Olomouc, Pilsen, Prague)
17:20
End of programme
PRAGUE (Room E – 1st floor)
8:00-9:30
News in Treatment of Metabolic Syndrome
Supported by AstraZeneca Educational Grant
Chairpersons: J. Hradec, J. Špinar (Prague, Brno)
8:00
434.
DIABETES MELLITUS - INCRETINS
8:15
435.
DIABETES MELLITUS - SGLT2 INHIBITORS (GLIFLOZINS)
J. Škrha (Prague)
8:30
436.
DYSLIPIDAEMIA - EZETIMIBE
J. Špinar (Brno)
8:45
437.
DYSLIPIDAEMIA - PCSK9 INHIBITORS
P. Janský (Prague)
9:00
438.
PHARMACOTHERAPY OF OBESITY
M. Souček (Brno)
9:15
Discussion
9:30-10:30
Czech Society of Angiology
Aortic Diseases
Chairpersons: D. Kučera, P. Vařejka (Ostrava, Prague)
9:30
439.
CURRENT OPTIONS OF ENDOVASCULAR TREATMENT OF AORTIC DISEASES
S. Heller (Prague)
9:50
440.
LONG-TERM RESULTS OF FLEXIBLE STENT GRAFT IMPLANTATION FOR ABDOMINAL
AORTIC ANEURYSMS
P. Vařejka (Prague)
10:10 441.
ABDOMINAL AORTIC IMPAIRMENT IN THORACIC AORTIC DISSECTION, PROGNOSIS,
ENDOVASCULAR AND HYBRID APPROACH
D. Kučera (Ostrava)
10:30
Break
11:00-12:30
Hotlines
Chairpersons: P. Janský, L. Špinarová (Prague, Brno)
11:00 442.
COSMIC-HF
11:09 443.
SOCRATES
J. Vítovec (Brno)
11:18 444.
PARADIGM-HF
11:27 445.
SPRINT
M. Souček (Brno)
11:36 446.
HOPE 3
P. Janský (Prague)
11:45 447.
ARTS-HF
J. Hradec (Prague)
11:54 448.
TECOS
J. Olšovský (Brno)
12:03 449.
ATMOSPHERE
12:12 450.
SOCRATES
A. Tomek (Prague)
12:21 451.
EMPA-REG
J. Špinar (Brno)
12:30
Lunch break
13:00-14:00
SERVIER s.r.o. Symposium
New Hope for Patients with Heart Failure
In Cooperation with Czech Association of Heart Failure
Chairpersons: J. Špinar (Brno)
13:00 452.
HEART FAILURE – EPIDEMIC OF THE 21ST CENTURY OR WHY IS 2016 THE YEAR OF
HEART FAILURE IN CZECH REPUBLIC
J. Špinar (Brno)
13:20 453.
THE ROLE OF IVABRADINE IN THE MANAGEMENT OF HEART FAILURE
M. Cowie (London, United Kingdom)
13:40 454.
POSSIBILITIES OF TREATMENT OPTIMALIZATION IN PATIENTS WITH CHRONIC
HEART FAILURE IN CASE REPORTS AND IMAGES
F. Málek (Prague)
14:00
Break
14:10-15:10
How to deal with Arrhythmology Issues in Patients - Exemplary Case Reports
Chairpersons: J. Kautzner, L. Haman (Prague, Hradec Králové)
14:10 455.
LEFT VENTRICULAR DYSFUNCTION IN PATIENT WITH FREQUENT VENTRICULAR
ECTOPY
B. Aldhoon (Prague)
14:22 456.
SUDDEN WORSENING IN PATIENT WITH CARDIAC RESYNCHRONIZATION THERAPY
M. Novák (Brno)
14:34 457.
PATIENT WITH ELECTRICAL STORM
J. Škoda (Prague)
14:46 458.
PATIENT WITH RECURRENT NEUROCARDIOGENIC SYNCOPE AND ASYSTOLE
D. Wichterle (Prague)
14:58
Discussion
15:10
Break
15:15-16:15
Working Group of Valvular and Congenital Heart Diseases in Adults
Left Atrial Appendage Exclusion as Management of Risk of Thromboembolism in
Atrial Fibrillation
In Cooperation wtih Czech Association for Heart Rhythm
Chairpersons: A. Mokráček, J. Petrů (České Budějovice, Prague)
15:15 459.
ARRHYTHMOGENESIS IN MITRAL VALVE DISEASES IN RELATION TO MORPHOLOGY
AND FUNCTION OF LEFT ATRIUM AND APPENDAGE
D. Marek (Olomouc)
15:30 460.
PERIPROCEDURAL TOE EXAMINATION OF THE LEFT ATRIAL APPENDAGE AND
NAVIGATION DURING CATHETER-BASED CLOSURE
T. Mráz (Prague)
15:45 461.
CATHETER-BASED LEFT ATRIAL APPENDAGE OCCLUSION
P. Neužil (Prague)
15:55 462.
OPTIONS OF SURGICAL LEFT ATRIAL APPENDAGE EXCLUSION
A. Mokráček (České Budějovice)
16:05
Discussion
16:15
Break
16:20-17:20
Free Lectures - Acute Coronary Syndromes
Chairpersons: M. Aschermann, R. Rokyta (Prague, Pilsen)
16:20 463.
DECREASING DIFFERENCES IN TREATMENT OF MEN AND WOMEN WITH ACS ANALYSIS OF CZECH-1 AND CZECH-2 REGISTRY
S. Šimek, F. Toušek, D. Horák , L. Pešl, F. Holm, Z. Moťovská, J. Jarkovský, M.
Aschermann, P. Widimský (Prague)
16:30 464.
NATURAL DEVELOPMENT OF STENT MALPOSITIONING IN PATIENTS
TREATED BY DIRECT PERCUTANEOUS CORONARY INTERVENTION: SUBANALYSIS OF
“ROBUST“ STUDY
M. Jakl, P. Červinka, P. Kala, J. Kaňovský, A. Kupec, A. Schnell, H. Bezerra (Hradec
Králové, Ústí nad Labem, Brno, Cleveland, United States)
16:40 465.
TROPONIN LEVELS IN PATIENTS WITH STABLE CAD
J. Daněk, T. Hnátek, M. Malý , J. Běláček, L. Pospíšilová, J. Škvařil, M. Hajšl, M.
Černohous, P. Sedloň, M. Zavoral (Prague)
16:50 466.
EARLY DISCHARGE (48-72 HOURS) OF LOW-RISK PATIENTS AFTER ACUTE ST
ELEVATION MYOCARDIAL INFARCTION - INTERIM RESULTS OF MONOCENTRIC, OPEN
RANDOMIZED TRIAL
K. Novobílský, P. Černý, I. Horák, V. Kaučák, R. Štípal, J. Mrózek, R. Kryza (Ostrava)
17:00 467.
REGISTRY OF ACUTE CORONARY SYNDROMES - CZECH-3 REGISTRY
P. Toušek, P. Červinka, F. Toušek, O. Hlinomaz, M. Malý, M. Sluka, Z. Coufal (Prague,
Ústí nad Labem, České Budějovice, Brno, Olomouc, Zlín)
17:10 468.
OCCURRENCE OF LOCALBLEEDING AND THROMBOTIC COMPLICATIONS IN PATIENTS
AFTER TRANSRADIAL PRIMARY PCI TREATED WITH THREE DIFFERENT P2Y12
INHIBITORS
M. Hromádka, I. Bernat, J. Seidlerová, E. Dragounová, V. Pechman , Š. Jirouš , O.
Sirotek, P. Tůmová, R. Rokyta (Pilsen)
17:20
End of programme
8:00-9:30
Multimodality Imaging in Pulmonary Hypertension
Chairpersons: E. Mandysová, M. Hutyra (Prague, Olomouc)
8:00
469.
ECHOCARDIOGRAPHY
M. Hutyra (Olomouc)
8:15
470.
MRI
M. Pleva (Ostrava)
8:30
471.
CT
V. Černý (Prague)
8:45
472.
INVASIVE ANGIOGRAPHY
S. Heller (Prague)
9:00
473.
SCINTIGRAPHIC METHODS
O. Lang (Prague)
9:15
Discussion
9:30-10:30
Subsegmental Pulmonary Embolism – To Treat or Not To Treat?
Chairpersons: O. Lang, Z. Moťovská (Prague, Příbram, Prague)
9:30
474.
CLINICAL SIGNIFICANCE OF ASYMPTOMATIC PULMONARY EMBOLISM
P. Dulíček (Hradec Králové)
9:42
475.
RISKS AND BENEFITS OF ANTICOAGULATION THERAPY IN SUBSEGMENTAL
PULMONARY EMBOlISM
9:54
476.
ROLE OF CT PULMONARY ANGIOGRAPHY IN SUSEGMENTAL PULMONARY
EMBOLISM
J. Weichet (Prague)
10:06 477.
ROLE OF LUNG SCINTIGRAPHY IN SUBSEGMENTAL PULMONARY EMBOLISM
O. Lang (Prague)
10:18
Discussion
10:30
Break
11:00-12:30
Arrhythmology 2016: Is Everything Clear?
Chairpersons: P. Neužil, P. Pařízek (Prague, Hradec Králové)
11:00 478.
HYBRID (TREATMENT) VS. CATHETER-BASED TREATMENT IN LONG-STANDING ATRIAL
FIBRILLATION. PROS
A. Bulava (České Budějovice)
11:12 479.
HYBRID (TREATMENT) VS. CATHETER-BASED TREATMENT IN LONG-STANDING ATRIAL
FIBRILLATION. CONS
M. Fiala (Třinec)
11:24
Discussion
11:30 480.
IS THROMBOEMBOLISM RISK STRATIFICATION WITH CHA2DS2-VASC SCORE IN
ATRIAL FIBRILLATION OPTIMAL? PROS
P. Osmančík (Prague)
11:42 481.
IS THROMBOEMBOLISM RISK STRATIFICATION WITH CHA2DS2-VASC SCORE IN
ATRIAL FIBRILLATION OPTIMAL? CONS
R. Čihák (Prague)
11:54
Discussion
12:00 482.
SHOULD ALL PATIENTS WITH LVEF UNDER 35% HAVE ICD? PROS
L. Křivan (Brno)
12:12 483.
SHOULD ALL PATIENTS WITH LVEF UNDER 35% HAVE ICD? CONS
M. Kozák (Brno)
12:24
Discussion
12:30
Lunch break
13:00-14:00
Boehringer Ingelheim spol. s r.o. Symposium
Dabigatran and Idarucizumab in Case Reports – Tips and Tricks for Clinical Practice
Chairperson: J. Veselý (Náchod)
13:00 484.
ARRHYTHMOLOGIST’S VIEW
J. Šimek (Prague)
13:15 485.
ANGIOLOGIST’S VIEW
R. Malý (Hradec Králové)
13:30 486.
CARDIOLOGIST’S VIEW
J. Matoušková (Prague)
13:45 487.
NEUROLOGIST’S VIEW
D. Šaňák (Olomouc)
14:00
Break
14:10-15:10
How to Treat Heart Failure According to Severity
Chairpersons: J. Hradec, L. Špinarová (Prague, Brno)
14:10 488.
PREVENTION AND ASYMPTOMATIC DYSFUNCTION
14:25 489.
SYMPTOMATIC DYSFUNCTION
J. Hradec (Prague)
14:40 490.
ADVANCED AND TERMINAL HEART FAILURE
I. Málek (Prague)
14:55 491.
CARE AFTER DISCHARGE FROM HOSPITAL
J. Vítovec (Brno)
15:10
Break
15:15-16:15
AHEAD - Acute Heart failure Database
Chairpersons: F. Málek, J. Bělohlávek (Prague)
15:15 492.
PATIENT WITH ACUTE HEART FAILURE, TREATMENT COMPLICATIONS, LONG-TERM
PROGNOSIS
J. Pařenica (Brno)
15:35 493.
FACTORS INFLUENTING PROGNOSIS OF ACUTE HEART FAILURE – GENDER
DIFFERENCES, OBESITY PARADOX ....
15:55 494.
PROGNOSTIC STRATIFICATION MODEL - AHEAD SCORE
J. Špinar (Brno)
16:15
Break
16:20-18:00
Free Lectures - Heart Failure, Transplantation
Chairpersons: J. Špinar, L. Špinarová (Brno)
16:20 495.
PREVALENCE OF SLEEP APNOEA AS RISK FACTOR OF SUDDEN CARDIAC DEATH IN
PATIENTS WITH ISCHEMIC AND DILATED CARDIOMYOPATHY
T. Kára, M. Novák, M. Táborský, M. Bělehrad, J. Lipoldová, P. Hude, J. Krejčí, O. Ludka,
V. Somers (Olomouc, Brno, Rochester, United States)
16:30 496.
DOES NON-ADHERENCE TO PHARMACOTHERAPY AFFECT PROGNOSIS OF PATIENTS
WITH CHRONIC HEART FAILURE?
R. Pelouch, M. Solař, V. Voříšek, J. Ceral, V. Furmanová (Hradec Králové)
16:40 497.
PERIPARTUM CARDIOMYOPATHY – RARE CAUSE OF HEART FAILURE
L. Gajdošová (Olomouc)
16:50 498.
LONG-TERM PROGNOSIS OF PATIENTS WITH MODERATE AND SEVERE SLEEP APNOEA
AFTER ACUTE MYOCARDIAL INFARCTION DEPENDING ON LEFT VENTRICULAR
SYSTOLIC FUNCTION
O. Ludka, R. Štěpánová, L. Galková, M. Mikolášková, M. Bělehrad, J. Košťálová, Z.
Mihalová, B. Fischerová, T. Kára, J. Špinar (Brno, Olomouc)
17:00 499.
PROGNOSIS OF OUTPATIENTS AND INPATIENTS WITH HEART FAILURE IN CZECH
REPUBLIC AND EUROPE. DATA FROM ESC HEART FAILURE LONG-TERM REGISTRY –
RESULTS OF 1-YEAR FOLLOW-UP
J. Krupička, A. Andrušková, M. Hegarová, M. Lazárová, F. Málek, M. Mikolášková, H.
Poloczková, D. Vondráková, J. Hradec (Prague, Znojmo, Olomouc, Brno)
17:10 500.
GEOGRAPHICAL DIFFERENCES IN THE AVAILIBILITY OF HEART TRANSPLANTATION IN
CZECH REPUBLIC
J. Beneš, S. Pasnišinová, P. Němec, H. Bedáňová, J. Pirk, I. Málek, J. Kautzner, V.
Melenovský (Prague, Brno)
17:20 501.
IMPORTANCE OF RIGHT VENTRICULAR STROKE WORK INDEX IN OPTIMALIZATION OF
APPROPRIATE CANDIDATE SELECTION FOR IMPLANTATION OF LEFT VENTRICULAR
ASSIST DEVICE
E. Ozábalová, J. Krejčí, P. Hude, J. Godava, T. Honek, J. Lipoldová , H. Bedáňová, P.
Němec, L. Špinarová (Brno)
17:30 502.
CARDIAC TRANSPLANTATION AND CARDIAC CELLULAR PROGENITOR ANALYSIS IN
DYSTROPHIN CARDIOMYOPATHY
M. Pešl, Š. Jelínková, M. Holická, V. Žampachová, R. Gaillyová, P. Němec, J. Krejčí, P.
Dvořák, Z. Stárek, V. Rotrekl (Brno)
17:40 503.
DO DIFFERENT TYPES OF IMPLANTED LONG-TERM MECHANICAL CIRCULATORY
SUPPORTS (LVAD) AFFECT OUTCOMES AFTER HEART TRANSPLANT?
H. Bedáňová, J. Ondrášek, V. Horváth, P. Fila, M. Šebo, P. Pokorný, J. Krejčí, P. Hude,
P. Němec (Brno)
17:50 504.
FUNCTION OF LEFT ATRIUM IN PATIENTS WITH CHRONIC RENAL FAILURE
J. Malík, J. Kudlička, J. Lachmanová, A. Valeriánová (Prague)
18:00
End of programme
8:30-9:30
Working Group of Cardiovascular Rehabilitation
Stress Tests in Practice - Interesting Case Reports
Chairpersons: L. Špinarová, F. Juráň (Brno, Hranice na Morävě)
8:30
505.
STRESS TESTS IN ADULT ATHLETES OR DID HE HAVE IT ?
E. Sovová (Olomouc)
8:50
506.
INDICATION OF STRESS ECHOCARDIOGRAPHY FOR VALVULAR HEART DISEASE
SURGERY
M. Troubil (Olomouc)
9:10
507.
STRESS TESTS IN CHILDREN WITH CONGENITAL HEART DISEASES
J. Radvanský (Prague)
9:30-10:30
Cardiovascular Rehabilitation – Working Group
Cardiovascular Rehabilitation - How to Deal With It?
Chairpersons: E. Sovová, L. Elbl (Olomouc, Brno)
9:30
508.
CARDIOVASCULAR REHABILITATION IN PATIENTS WITH HEART FAILURE
9:50
509.
CARDIOVASCULAR REHABILITATION IN PATIENTS WITH CORONARY ARTERY DISEASE
AND IN PATIENTS WITH PACEMAKER OR ICD
H. Skalická, I. Karel (Prague)
10:10 510.
CARDIOVASCULAR REHABILITATION IN PATIENTS WITH VALVULAR HEART DISEASES
I. Karel, H. Skalická (Prague)
10:30
Break
11:00-12:30
Czech Association of Outpatient Cardiologists
Case Reports in Outpatient Practice
Chairpersons: I. Karel, V. Danzig, P. Lindovský (Prague)
11:00 511.
FREQUENT VENTRICULAR ECTOPY AS POSSIBLE CAUSE OF RECURRENT FALLS IN
YOUNG FEMALE PATIENT – CASE REPORT
M. Schejbalová (Prague)
11:09 512.
CONGENITAL HEART DISEASES DIAGNOSED IN ADULTHOOD – SURPRISE IN
CARDIOLOGY OUTPATIENT CLINIC
G. Dostálová, J. Marešová, Z. Hlubocká, K. Bayerová, T. Paleček, D. Wichterle, J.
Hlubocký, T. Grus, J. Lindner, A. Linhart (Prague)
11:18 513.
DEFIBRILLATOR-PACEMAKER-RESPIRATOR OR EVERYTHING IS USUALLY DIFFERENT
J. Píšová, P. Pařízek , M. Tauchman, M. Kopecký (Hradec Králové)
11:27 514.
TETRALOGY OF FALLOT IN CONTEXT OF GOOD LIFE PROGNOSIS
R. Jirmář, P. Povolná, J. Popelová (Prague)
11:36 515.
PRESSURE TREATMENT OF BRADYARRHYTHMIAS
V. Danzig, M. Válek, M. Pretl (Prague)
11:45 516.
DIFFICULTIES IN FOLLOW-UP OF PATIENT AFTER BENTALL SURGERY
H. Lubanda, J. Lubanda (Prague)
11:54 517.
DIAGNOSTIC DIFFICULTIES IN PATIENT WITH PRIMARY PULMONARY HYPERTENSION
I. Karel (Prague)
12:03 518.
MAY MALIGNANT TUMOR AFFECT ECG?
M. Rýzlová (Prague)
12:12 519.
CHEST PAIN IN 42-YEAR-OLD MAN
J. Václavík (Olomouc)
12:21 520.
PERSISTENT LEFT SUPERIOR VENA CAVA – DIAGNOSIS, CLINICAL SIGNIFICANCE
12:30
Lunch break
13:00-14:00
Merck Sharp & Dohme s.r.o. Symposium
MSD Strong Evidence
Chairperson: R. Češka (Prague)
13:00 521.
IMRPOVE IT: A LITTLE OR A LOT?
R. Češka (Prague)
13:20 522.
TWO SPECIALTIES – ONE GOAL: DIABETES
M. Kvapil (Prague)
13:40 523.
INOPERABLE CTEPH: NOWADAYS, PULMONARY EMBOLISM COMPLICATION WHICH IS
ALREADY SUCCESSFULLY TREATABLE
P. Jansa (Prague)
14:00
Break
14:10-15:10
Working Group of Preventive Cardiology
Influencing of Major Cardiovascular Risk Factors in Young Adults.
Chairpersons: H. Vaverková, R. Cífková (Olomouc, Prague)
14:10 524.
IMPORTANCE AND TREATMENT OF DYSLIPIDAEMIA IN YOUNG ADULTS
14:30 525.
ARTERIAL HYPERTENSION IN YOUNG ADULTS
R. Cífková (Prague)
14:50 526.
POSSIBILITIES OF INFLUENCING CARDIOVASCULAR RISK IN YOUNG PATIENTS WITH
PREDIABETES AND DIABETES
M. Kvapil (Prague)
15:10
Break
15:15-16:15
Guidelines for Indications, Performance, and Interpretation of Myocardial SPECT
Imaging
Chairpersons: M. Kamínek, A. Fikrle (Olomouc, Prague)
15:15 527.
BENEFITS OF STRESS IMAGING METHODS IN STRATEGY OF DIAGNOSIS AND
TREATMENT OF CAD
K. Mědílek (Hradec Králové)
15:35 528.
RECOMMENDATIONS FOR PERFORMING OF MYOCARDIAL SPECT AND SPECT/CT
M. Kamínek (Olomouc)
15:55 529.
RECOMMENDATIONS FOR INTERPRETATION AND REPORTING OF MYOCARDIAL
SPECT
A. Fikrle (Prague)
16:15
Break
16:20-17:10
Free Lectures – Pharmacotherapy, Outpatient Care
Chairpersons: P. Janský, V. Danzig (Prague)
16:20 530.
PULMONARY IMPAIRMENT IN AMIODARONE TREATMENT
E. Střídová (Olomouc)
16:32 531.
REDUCTION OF ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY
ANGIOPLASTY IN PATIENTS RECQUIRING LONG-TERM ORAL ANTICOAGULATION
M. Sluka, J. Ostřanský, D. Richter, M. Škvařilová, D. Vindiš (Olomouc)
16:44 532.
POSSIBILITIES OF USE OF HIGH FREQUENCY ECG DURING STRESS TESTING FOR
DIAGNOSIS OF CORONARY ARTERY DISEASE
K. Bayerová, H. Skalická, T. Kovárník, V. Danzig, Š. Jeřábek, A. Linhart, J. C. Lubanda
(Prague)
16:56 533.
COR TRIATRIATUM – THE PRESENCE OF RARE ECHOCARDIOGRAPHIC FINDING DOES
NOT EXCLUDE ANOTHER CAUSE OF CLINICAL SYMPTOMS
P. Povolný, E. Mandysová (Kladno, Prague)
17:10
End of programme
8:30-9:30
Specific treatments for hypertrophic cardiomyopathy
Chairpersons: P. Gregor, D. Zemánek (Prague)
8:30
534.
FABRY DISEASE
A. Linhart (Prague)
8:50
535.
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
J. Veselka (Prague)
9:10
536.
CARDIAC AMYLOIDOSIS
9:30-10:30
Free Lectures - Myocardial and Pericardial Diseases
Chairpersons: P. Hude, M. Kubánek (Brno, Prague)
9:30
537.
HEART IMPAIRMENT IN PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS
M. Bělobrádková, Z. Bělobrádek, T. Rozkoš, M. Kopáčová, T. Soukup (Hradec Králové)
9:40
538.
DOES FAMILY HISTORY PREDICT PROGRESSION IN DILATED OR INFLAMMATORY
CARDIOMYOPATHY?
A. Chaloupka, J. Krejčí, J. Máchal, D. Mlejnek, D. Sochorová, E. Ozábalová, P. Hude, L.
Špinarová (Brno)
9:50
539.
ONE YXOMA IN NOT LIKE ANOTHER OR WHEN THE PATHOLOGIST IS SAVING LIVES
P. Roučka, T. Hájek, M. Zárybnická, D. Kacerovská , D. Kazakov, M. Michal, O. Hes, Z.
Chudáček , M. Hora , I. Třešková (Pilsen)
10:00 540.
MUTATIONS IN GENES ASSOCIATED WITH ARRHYTHMOGENIC
CARDIOMYOPATHY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
P. Tomašov, P. Norambuena, D. Jahnlová, J. Bonaventura, M. Macek, J. Veselka
(Prague)
10:10 541.
IMPORTANCE OF RIGHT VENTRICULAR FUNCTION FOR PREDICTION OF
DEVELOPMENT OF ECHOCARDIOGRAPHIC PARAMETERS IN PATIENTS WITH
IMFLAMMATORY CARDIOMYOPATHY
J. Krejčí, D. Sochorová, P. Hude, E. Ozábalová, D. Mlejnek, V. Žampachová, R.
Štěpánová, L. Špinarová (Brno)
10:20 542.
PERICARDIOCENTESIS CONTROLLED BY ECHOCARDIOGRAPHY – METHOD OF CHOICE
FOR PERICARDIAL EFFUSION TREATMENT AFTER CARDIAC SURGERY: EXPERIENCE OF
ONE CENTRE, 2004-2015
M. Kolek (Ostrava)
10:30
Break
11:00-12:30
Working Group of Valvular and Congenital Heart Diseases In Adults
Prosthetic Valves – How to Deal with it?
Chairpersons: Š. Černý, M. Brtko (Prague, Hradec Králové)
11:00 543.
(Prague)
11:15 544.
FLUOROSCOPY OF MECHANICAL VALVE PROSTHESIS
K. Kopřiva, M. Mates, J. Popelová, P. Kmoníček, O. Aschermann, P. Formánek
BENEFITS OF 3D ECHOCARDIOGRAPHY IN ASSESSMENT OF VALVE PROSTHESES
S. Kovalová (Brno)
11:30 545.
BIOPROSTHESES IN YOUNG PATIENTS?
11:45 546.
SURGEON’S VIEW
J. Škorpil (Pilsen)
12:00 547.
INFECTIVE ENDOCARDITIS IN BIOLOGICAL AND MECHANICAL PROSTHESES
M. Brtko (Hradec Králové)
12:15
Discussion
12:30
Lunch break
13:00-14:00
AMGEN s.r.o. Symposium
Beginning of a New Era In Treatment of Dyslipidaemia
Chairpersons: M. Táborský (Olomouc)
14:00
Break
14:10-15:10
Pulmonary Circulation – Working Group
Discussed and Disputable Topics in Pulmonary Hypertension
Chairpersons: M. Aschermann, P. Jansa (Prague)
14:10 548.
DRUG-INDUCED PULMONARY ARTERIAL HYPERTENSION
P. Jansa (Prague)
14:25 549.
PULMONARY HYPERTENSION IN LIVER CIRRHOSIS
14:40 550.
TREATMENT OF PULMONARY HYPERTENSION IN LEFT-SIDED HEART FAILURE
H. Al-Hiti (Prague)
14:55 551.
REGISTRED AND UNREGISTERED INDICATION OF PHARMACOTHERAPY FOR CTEPH
M. Aschermann (Prague)
15:10
Break
15:15-16:15
Working Group of Pulmonary Circulation
Cardiac Complications of Rheumatic Diseases
Chairpersons: P. Horák, P. Jansa (Olomouc, Prague)
15:15 552.
SSC, SLE, ANTIPHOSPHOLIPID SYNDROME
P. Horák (Olomouc)
15:30 553.
CARDIAC IMPAIRMENT IN SYSTEMIC SCLEROSIS
15:45 554.
CARDIAC IMPAIRMENT IN OTHER SYSTEMIC DISEASES
J. Vymětal (Olomouc)
16:00 555.
PULMONARY ARTERIAL HYPERTENSION
P. Jansa (Prague)
16:15
Break
16:20-17:20
Free lectures – Pulmonary Hypertension, Congenital Heart Diseases
Chairpersons: J. Mrózek, Š. Havránek (Ostrava, Prague)
16:20 556.
PREVALENCE AND CLINICAL SIGNIFICANCE OF ATRIAL FIBRILLATION AND ATRIAL
FLUTTER IN PATIENTS WITH PRECAPILLARY AND MIXED PULMONARY HYPERTENSION
Š. Havránek, D. Ambrož, Z. Fingrová, P. Jansa, R. Votavová, J. Lindner, J. Kunstýř, M.
Aschermann, A. Linhart (Prague)
16:30 557.
MODERN DRUG TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY
HYPERTENSION IN SLOVAKIA
M. Boháčeková, I. Šimková, A. Remková, T. Valkovičová, M. Kaldarárová (Bratislava,
SR)
16:40 558.
ODRA PROJECT - MONITORING OF PERFUSION DEFECTS’ REPERFUSION AFTER THE
FIRST EPISODE OF PULMONARY EMBOLISM
J. Mrózek, P. Bindas, V. Janovský, L. Kraus, J. Petrová, J. Václavková, P. Jansa (Ostrava,
Opava, Nový Jičín, Prague)
16:50 559.
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION, OUR EXPERIENCE IN
GENERAL HOSPITAL
M. Belicová, V. Jankovičová, M. Ochodnický, M. Mokáň (Martin, SR, Martin)
17:00 560.
CATHETER ABLATION OF ARRHYTHMIAS IN ADULTS WITH CONGENITAL HEART
DISEASE – LONG-TERM RESULTS OF A SPECIALIZED CENTRE
J. Škoda, J. Popelová, R. Gebauer, Š. Černý, J. Petrů, L. Šedivá, I. Skalský, V. Reddy, P.
Neužil (Prague, New York, United States)
17:10 561.
ANOMALOUS ORIGIN OF LEFT CORONARY ARTERY FROM THE PULMONARY ARTERY
DIAGNOSED INCIDENTALLY IN 46 YEARS – CASE REPORT
V. Fendrychová, T. Zatočil, A. Nečasová, T. Brychta, L. Koc (Brno)
17:20
End of programme
POSTER SESSION – DOCTORS (Room E 1st floor, foyer)
10:30-11:00
Moderated Poster Session 2
Moderated discussion will take place from 10.30 to 11.00. Evaluation
commission: P. Neužil, J. Špinar, J. Vítovec, H. Skalická (Prague, Brno)
562.
NATIVE T1 RELAXATION TIME AND MYOCARDIAL EXTRACELLULAR VOLUME ARE
ACCURATE MARKERS OF DIFFUSE MYOCARDIAL FIBROSIS IN HEART VALVE DISEASE: A
COMPARISON WITH LEFT VENTRICULAR MYOCARDIAL BIOPSY
R. Kočková, P. Kačer, J. Pirk, L. Súkupová, V. Šikula, M. Kotrč, A. Pravečková, L.
Barčiaková, D. Sedmera, M. Pěnička (Prague, Aalst, Belgium)
563.
PREVALENCE OF PULMONARY HYPERTENSION AFTER PULMONARY EMBOLISM
DETECTED BY ECHOCARDIOGRAPHY
J. Šmrha, P. Kessler, J. Foltin, H. Poul, P. Koudelková , M. Harudová (Pelhřimov)
564.
IMPAIRED CEREBROVASCULAR REACTIVITY WITHOUT SIGNIFICANT STENOSIS OF
CAROTID ARTERY IS ASSOCIATED WITH RISK OF ISCHAEMIC STROKE IN PATIENTS
WITH CORONARY ARTERY DISEASE AND SINUS RHYTHM
Z. Rücklová, D. Ručka, J. Marek, Š. Havránek, J. Škvařil, J. Lubanda, A. Linhart, J.
Kořínek (Prague)
565.
TERMINATION OF PREGNANCY IN DETECTION OF A CONGENITAL HEART DISEASE IN
THE FETUS
J. Pavlíček, T. Gruszka, S. Polanská (Ostrava)
566.
TRANSOESOPHAGEAL ECHOCARDIOGRAPHY UNDERESTIMATES TRANSVALVULAR
GRADIENT AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) IMPLICATIONS FOR CLINICAL PRACTICE
A. Solčanová, S. Bates, N. Curzen, A. Calver, B. Shah, D. Rakhit (Southampton, United
Kingdom, Southampton)
567.
DOES TELOMERE LENGTH MEASURED IN AORTIC TISSUE HAVE IMPACT ON THE FATE
OF HEART TRANSPLANT PATIENTS?
J. Vymětalová, D. Dlouhá, J. Hubáček, V. Lánská, I. Málek (Prague)
568.
RETROSPECTIVE COMPARISON OF AORTIC VALVE MORPHOLOGY ASSESSMENT BY
ECHOCARDIOGRAPHY AND CT BEFORE TAVI
P. Kmoníček, M. Mates, T. Mráz , J. Weichet (Prague)
569.
EFFECT OF SPINAL CORD STIMULATION ON HEART FAILURE ASSOCIATED
BIOMARKERS IN PATIENT WITH CHRONIC SYSTOLIC HEART FAILURE
P. Doškář, M. Ståhlberg, J. Naar, F. Málek, D. Jaye, C. Linde, F. Braunschweig, L.
Mortensen, M. Bäck, P. Neužil (Prague, Stockholm, Sweden, Minneapolis, United
States)
570.
PREDICTIVE VALUE OF HLA AND MICA ANTIBODIES MONITORING DURING THE FIRST
YEAR AFTER HEART TRANSPLANTATION
T. Gazdič, I. Málek, M. Rodová, A. Slavčev, V. Lánská, L. Voska, J. Pirk (Prague)
571.
YEAR MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION DISCHARGED AFTER
MAJOR NON-CARDIAC SURGERY – THE IMPACT OF NON-EARLY INITIATION OF
ANTITHROMBOTIC THERAPY ON MORTALITY
M. Ondráková, Z. Moťovská, J. Knot, P. Waldauf, P. Widimský (Prague)
11:00-18:00
572.
Poster Session 2
ACQUIRED ARTERIOVENOUS MALFORMATION CAUSING HYPERKINETIC HEART
FAILURE
J. Rychlík, D. Foldyna, S. Heller, J. Hlas, Z. Klimsa, H. Mischková (Jihlava, Prague)
573.
ISOLATED NON-COMPACTION CARDIOMYOPATHY AS RARE CAUSE OF
HEART FAILURE
S. Skopoulis, N. Suková, P. Frídl, R. Feuereisl (Prague, Liberec)
574.
HEART FAILURE WITH PRESERVED EJECTION FRACTION – DIFFERENTIAL DIAGNOSIS
J. Josiek (Třinec)
575.
LISTERIAL MYOCARDITIS AS COMPLICATION OF LISTERIAL MENINGO-ENCEPHALITIS
M. Strnadel, T. Hnátek, E. Krčová, R. Havlíček, M. Malý, M. Zavoral (Prague)
576.
COMMON FH MUTATION IN LDL RECEPTOR GENE - CHARACTERISTICS OF CARRIERS
FROM THE POPULATION SAMPLE.
J. Hubáček, A. Fellnerová, D. Dlouhá, V. Adámková (Prague)
577.
PERICARDIAL CYST – ATYPICAL CAUSE OF CHEST PAIN
M. Plíva, J. Večeřa, M. Děrgel (Pardubice, Hradec Králové)
578.
UNUSUAL CAUSE OF VENTRICULAR TACHYCARDIAS IN YOUNG MALE PATIENT
K. Vykoupil, J. Pyszko, M. Fedorco, J. Galuszka, P. Heinc, M. Táborský (Olomouc,
Prostějov)
579.
THE ROLE OF STRUCTURAL AND FUNCTIONAL ASYMMETRY IN THE CIRCULATION
T. Kenner, D. Platzer (Graz, Austria, Graz)
580.
ACUTE CORONARY SYNDROME; WITHOUT PROOF OF OBSTRUCTIVE
ATHEROSCLEROSIS - ROLE OF MAGNETIC RESONANCE IMAGING
J. Borová , M. Pleva (Třinec)
581.
PREDICTION OF SEVERE RENAL FAILURE IN PATIENTS AFTER IMPLANTATION OF THE
HEARTMATE II
M. Holek, J. Kettner, J. Franeková, A. Jabor (Prague)
582.
EFFECT OF RENAL DENERVATION ON GLUCOSE METABOLISM AFTER 36-MONTH
FOLLOW-UP
E. Šušková, O. Jiravský, I. Nykl, M. Branny (Třinec)
583.
EXTENSIVE PULMONARY EMBOLIZATION, WITHOUT COR PULMONALE ON ECHO
B. Holek, R. Špaček, M. Branný (Třinec)
584.
RECURRENT IDIOPATHIC PERICARDIAL EFFUSION WITH NEED FOR SURGICAL
FENESTRATION OF THE PERICARDIUM – CASE REPORT
P. Grossmannová, V. Kaučák, R. Jursa, I. Horák, P. Buzrla (Ostrava)
585.
PRE-CAPILLARY PULMONARY HYPERTENSION OF COMBINED AETIOLOGY
P. Přenosilová, G. Štěrbáková, V. Beránek, J. Koza, R. Rokyta, M. Matějovič (Pilsen)
586.
SUCCESSFUL PROLONGED RESUSCITAION FOR CARDIAC ARREST FOLLOWED BY
IMPLANTATION OF 2 MECHANICAL CIRCULATORY SUPPORTS
K. Baranová, M. Levčík, J. Kettner (Prague)
587.
TARGET PROTEOMIC ANALYSIS OF SELECTED PLASMA MARKERS IN PATIENTS
WITH HYPERTROPHIC CARDIOMYOPATHY AND THEIR COMPARISON WITH OTHER
CARDIOVASCULAR DISEASES
A. Myslivcová Fučíková, H. Řehulková, L. Horáková, P. Řehulka, V. Řeháček, R. Pudil, J.
Stulík (Hradec Králové)
588.
IMPORTANCE OF ENDOMYOCARDIAL BIOPSY IN DETECTING THE CAUSES OF LEFT
VENTRICULAR DYSFUNCTION OF NON-ISCHAEMIC AETIOLOGY.
R. Aiglová, M. Táborský, T. Tichý (Olomouc)
589.
MITRAL STENOSIS DUE TO PANNUS OVERGROWTH AFTER MITRAL ANNULOPLASTY
Z. Hlubocká, G. Dostálová , J. Hlubocký, T. Paleček , J. Lindner, M. Aschermann, A.
Linhart (Prague)
590.
ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL WITH
MORPHOLOGICAL AND FUNCTIONAL PARAMETERS IN PATIENTS WITH
HYPERTROPHIC CARDIOMYOPATHY
R. Pudil, M. Vašatová, A. Fučíková, H. Řehulková, P. Řehulka, V. Palička, J. Stulík
(Hradec Králové)
591.
LEVEL OF NT-PROBNP AND MARKERS OF MYOCARDIAL STRUCTURAL DAMAGE IN
PATIENTS WITH NON-OBSTRUCTIVE TYPE OF HYPERTROPHIC CARDIOMYOPATHY
R. Pudil, M. Vašatová, I. Karešová, A. Fučíková, L. Horáková, H. Řehulková, P. Řehulka,
V. Palička, J. Stulík (Hradec Králové)
592.
REACTIVE CHANGES OF LEFT AND RIGHT VENTRICLE DURING TRAINING OF
FREEDIVING
R. Pudil, M. Zajac (Hradec Králové, Prague)
593.
PROGNOSTIC SIGNIFICANCE OF DYNAMIC STRESS ECHOCARDIOGRAPHY – OUR
EXPERIENCE
L. Jukl, J. Večeřa, J. Vondrák, M. Kubrycht, M. Pavolko, P. Vojtíšek (Pardubice)
594.
TRANSCATHETER CLOSURE OF PARAVALVULAR LEAK ON MITRAL ANNULOPLASTY
USING MITRAL BRIDGE SYSTEM
M. Prokopová, T. Mráz, M. Mates , Š. Černý , P. Neužil (Prague)
595.
FAILURE OF ANTICOAGULATION THERAPY IN PREGNANT PATIENT WITH MECHANICAL
MITRAL PROSTHESIS.
K. Kubišová, L. Škňouřil, M. Branny (Třinec)
596.
METHODOLOGY OF FLUOROSCOPY OF MECHANICAL VALVE PROSTHESES
K. Kopřiva, M. Mates, P. Kmoníček, O. Aschermann, P. Formánek, J. Popelová
(Prague)
597.
RAPIDLY PROGRESSIVE HEART FAILURE IN PATIENT WITH RESTRICTIVE
CARDIOMYOPATHY IN LATE DIAGNOSED MULTIPLE MYELOMA. CASE REPORT
Z. Jadvišová, J. Sulženko, J. Knot, J. Ulman, F. Bednář , Z. Moťovská (Prague)
598.
LARGE LEFT ATRIAL MYXOMA AS A CAUSE OF SYNCOPES AND EXERTIONAL DYSPNEA
I. Pavlas, M. Tropp, K. Zeman, P. Branny (Frýdek-Místek, Třinec)
599.
COMPARISON OF INSULIN THERAPY MANAGED BY TELEMONITORING AND
CONVENTIONAL STRATEGY ON COMPENSATION OF DIABETES, LABORATORY AND
ULTRASONOGRAPHIC MARKERS OF ATHEROTHROMBOSIS IN DIABEIC PATIENTS WITH
CORONARY ARTERY DISEASE
I. Šimková, M. Táborský, M. Hutyra, M. Vícha (Olomouc)
600.
TISSUE DOPPLER ECHOCARDIOGRAPHY IN DIAGNOSIS OF FABRY DISEASE
J. Marek, D. Rob, L. Goláň, G. Dostálová, R. Cífková, A. Linhart (Prague)
601.
LEFT ATRIAL MYXOMA AS A CAUSE OF SYNCOPAL EVENTS
R. Válek, J. Nový , J. Cyrany, J. Harrer (Jičín, Hradec Králové)
602.
CARDIOLOGY IN SWEDEN, PERSONAL EXPERIENCE OF A CZECH DOCTOR AFTER THREE
YEARS OF WORK IN LARGE REGIONAL HOSPITAL IN SWEDEN
K. Riegel (Trollhättan)
603.
MEASUREMENT OF ARTERIAL STIFFNESS PARAMETERS IN CARDIOVASCULAR RISK
ASSESSMENT
M. Štroffeková, E. Szaboóvá, E. Harajdová, E. Kriššáková-Fatľová , A. Lišovská, M.
Hozman, A. Schee, M. Paďour (Karlovy Vary, Košice, SR, Košice)
604.
NORMALIZATION OF LEFT VENTRICULAR EJECTION FRACTION IN A FEMALE PATIENT
WITH FAMILIAL FORM OF DILATED CARDIOMYOPATHY AND PERIPARTAL HEART
FAILURE
L. Pavlů, A. Krebsová, L. Piherová, M. Macek Jr, J. Kautzner, M. Táborský, J. Petřková
(Olomouc, Prague)
605.
QTC INTERVAL PROLONGATION AND INCREASED DISPERSION OF QT AS POTENTIAL
MANIFESTATIONS OF CARDIOTOXICITY IN PATIENTS TREATED FOR OVARIAN
CARCINOMA
R. Pudil, I. Sedláková, F. Varhaník, R. Praus (Hradec Králové)
606.
RELATIONSHIP OF BIOMARKERS OF CARDIAC OVERLOAD, INFLAMMATION AND
REMODELING OF EXTRACELLULAR MATRIX TO ECHOCARDIOGRAPHIC PARAMETERS
OF HEART FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION
D. Vondráková, F. Málek, J. Dvořák, L. Sedláčková, L. Táborský, P. Neužil (Prague)
607.
UNDIAGNOSED CONGENITAL HEART DISEASE AS A CAUSE OF ACUTE HEART FAILURE
IN ADULTHOOD - CASE REPORT
F. Kratochvíl, K. Bayerová, G. Dostálová, Z. Hlubocká, J. Hlubocký, T. Grus, J. Lindner,
M. Aschermann, A. Linhart (Benešov, Prague)
608.
EXTENSIVE DISSECTION OF AORTIC ANEURYSM - 20-YEAR-SURVIVAL.
V. Kopal, P. Dulanský, R. Tarnoczy (Přerov)
609.
INFECTIVE ENDOCARDITIS IN THE AGE OF CARDIAC INTERVENTIONS – EXPERIENCE
FROM ONE CENTRE
T. Ondrúš, M. Pěnička, Y. Mo, G. Van Camp (Aalst, Belgium)
610.
ASSESSMENT OF LEFT VENTRICULAR FUNCTION IN SYSTEMIC SCLEROSIS AND MIXED
CONNECTIVE TISSUE DISEASE
J. Vymětal, M. Hutyra, A. Smržová, M. Skácelová, R. Metelka, P. Horák (Olomouc)
611.
OBSTRUCTIVE HYPERTHROPHIC CARDIOMYOPATHY AND AORTIC VALVE DISEASE IN
ELDERLY WOMAN – A CASE FOR CATHLAB OR SURGERY? CASE REPORT
A. Chaloupka, J. Krejčí, L. Groch, V. Horváth, L. Špinarová (Brno)
612.
COMPARING THE OPTIONS OF REMOTE MONITORING OF IMPLANTS ACCORDING TO
THE PROFILE OF INDIVIDUAL PATIENTS
V. Vejvoda, M. Šebestová, V. Vančura (Pilsen)
613.
DEVELOPMENT OF LEFT VENTRICULAR SYSTOLIC FUNCTION IN PATIENTS WITH
RECENTLY DIAGNOSED DILATED CARDIOMYOPATHY OF UNKNOWN AETIOLOGY AND
INITIAL EJECTION FRACTION <= 35%, TWO-YEAR PROSPECTIVE FOLLOW-UP
J. Podzimková, P. Kuchynka, B. Daněk, J. Marek, T. Paleček (Prague)
614.
IDIOPATHIC FOCAL FIBROSIS AS RARE CAUSE OF RESTRICTIVE CARDIOMYOPATHY
WITH SIMULTANEOUS PULMONARY IMPAIREMENT - CASE REPORT
J. Přeček, M. Hutyra, L. Gajdošová, D. Rozsívalová, V. Kolek, S. Brychtová, L.
Fryšáková, Z. Tüdös, M. Táborský (Olomouc)
615.
HYPERSENSITIVITY TO METALS OF ENVIRONMENTAL BURDEN IN PATIENTS WITH
INFLAMMATORY AND DILATED CARDIOMYOPATHY
J. Maňoušek, M. Felšöci, J. Pařenica, J. Krejčí (Brno)
616.
OMENTIN-1 AS POTENTIAL MARKER OF ACUTE MYOCARDIAL INFARCTION AND
CORONARY ATHEROSCLEROSIS?
A. Smékal, J. Václavík, D. Stejskal, R. Richterová, M. Švesták, M. Táborský (Olomouc,
Prostějov, Nový Jičín)
617.
ANTHROPOMETRIC PARAMETER DIFFERENCIES IN ROMA MINORITY
V. Adámková, J. Hubáček, V. Mrázová, V. Lánská, V. Olišarová, L. Šedová , V. Tóthová
(Prague, České Budějovice)
618.
SAFETY AND EFFICACY OF IMMUNOADSORPTION IN HEART TRANSPLANT PROGRAM
T. Gazdič, I. Málek, L. Pagáčová , A. Slavčev, M. Hegarová, L. Hošková, M. Kubánek, J.
Pirk (Prague)
619.
OCCURRENCE OF MYOCARDIAL CRYPTS IN AN UNSELECTED GROUP OF PATIENTS
WITH HYPERTROPHIC CARDIOMYOPATHY
M. Pleva, J. Borová, J. Januška (Ostrava, Třinec)
620.
ATYPICAL INTRACARDIAC FORMATIONS
Z. Vavera, M. Solař (Hradec Králové)
621.
ASSESSMENT OF CLOPIDOGREL RESISTANCE USING ADP-INDUCED AGGREGOMETRY
WITH A SPECIFIC INHIBITOR PG1
F. Kováčik, M. Hutyra , J. Přeček, O. Moravec , T. Skála, M. Táborský, L. Slavík, J.
Úlehlová, V. Krčová, A. Hluší (Olomouc)
622.
ASSESSMENT OF GENETIC VARIANTS ASSOCIATED WITH STATIN-RELATED
MYOPATHY
J. Petřková, L. Kocourková, V. Žižková, M. Táborský, M. Petřek (Olomouc)
Wednesday 18 May 2016
ROTUNDA (Room A)
8:30-9:30
Seleccted Emergencies in Acute Cardiology – How to Deal With It?
Chairpersons: J. Pařenica, M. Hromádka (Brno, Pilsen)
8:30
623.
WHEN NOT TO HESITATE AND CALL AMBULANCE
T. Kovárník (Prague)
8:42
624.
ACUTE CARDIAC PROBLEMS IN PREGNANCY
8:54
625.
CARDIAC TAMPONADE
M. Solař (Hradec Králové)
9:06
626.
PULMONARY EMBOLISM
R. Rokyta (Pilsen)
9:18
Discussion
9:30-10:30
Czech Association of Outpatient Cardiologists
Chronic Heart Failure: “How Cardiocentre Cooperates with Outpatient Cardiologist
and What Outpatient Cardiologist Expects from Cardiocentre in the Care of Their
Patient”
Chairpersons: I. Málek, V. Danzig, H. Skalická, J. Vítovec, F. Málek (Prague, Brno)
9:30
627.
CARE OF PATIENT AR RISK OF HEART FAILURE AND WITH ITS MILDER FORM
J. Vítovec (Brno)
9:40
628.
CARDIOCENTRE WITH TRANSPLANTATION PROGRAM: OUTPATIENT HEART
FAILURE CLINIC – CARE OF PATIENTS WITH SYMPTOMS OF CHRONIC FAILURE
M. Hegarová (Prague)
9:49
629.
CARDIOCENTRE WITHOUT TRANSPLANTATION PROGRAM: OUTPATIENT HEART
FAILURE CLINIC
FOLLOW-UP OF PATIENTS WITH SEVERE SYMPTOMS OF HEART FAILURE
F. Málek (Prague)
9:58
630.
OUTPATIENT CLINIC FOLLOW-UP AND TREATMENT OF PATIENTS WITH DIFFERENT
MANIFESTATIONS AND SEVERITY OF CHF, OUTPATIENT CLINIC IN CARDIOCENTRE
V. Danzig (Prague)
10:07 631.
OUTPATIENT CARDIOLOGISTS IN THE CARE OF PATIENTS WITH CHF REGARDLESS
OF THE NATURE OF THE DISEASE AND POSSIBLY THEIR SIMULTANEOUS OUTPATIENT
FOLLOW-UP IN CARDIOCENTRE
H. Skalická, I. Karel (Prague)
10:13
Discussion
10:30
Break
11:00-12:00
Atrial Fibrillation: What Else Could Be Interesting?
Chairpersons: R. Čihák, A. Bulava (Prague, České Budějovice)
11:00 632.
PATIENT MONITORING: WHEN, HOW, HOW MUCH AND FOR HOW MUCH?
V. Bulková (Prague)
11:12
Discussion
11:15 633.
AMIODARONE IN THE AGE OF CATHETER ABLATION: MEDICINE OR POISON?
P. Pařízek (Hradec Králové)
11:27
Discussion
11:30 634.
CARDIOVERSION: HOW SHOULD IT BE DONE?
V. Vančura (Pilsen)
11:42
Discussion
11:45 635.
LEFT ATRIAL APPENDAGE CLOSURE: IS IT ALREADY AN ALTERNATIVE TO
ANTICOAGULATION THERAPY?
P. Neužil (Prague)
11:57
Discussion
12:00
End of programme
PRAGUE (Room E – 1st floor)
8:30-10:30
Working Group Kardio 35
Selected Topics from Cardiology Attestation Questions
Chairpersons: M. Pazderník, M. Šnorek (Prague, České Budějovice)
8:30
636.
CARE OF PATIENTS WITH CONGENITAL HEART DISEASE AND PATIENTS AFTER
CORRECTION OF CONGENITAL HEART DISEASE
9:00
637.
PATHOPHYSIOLOGY OF AORTIC VALVE DISEASES
A. Linhart (Prague)
9:20
638.
SYNCOPE
9:40
639.
SUDDEN DEATH
10:00 640.
STROKES
10:30
Break
11:00-12:00
Multimodality Imaging in Heart Failure with Preserved Systolic Function
Chairpersons: T. Paleček, K. Linhartová (Prague)
11:00 641.
ROLE OF ECHOCARDIOGRAPHY
J. Meluzín (Brno)
11:15 642.
ROLE OF MAGNETIC RESONANCE IMAGING
11:30 643.
ROLE OF NUCLEAR CARDIOLOGY
A. Fikrle (Prague)
11:45
Discussion
12:00
End of programme
8:30-10:00
Reversible Cardiomyopathies
In Cooperation with Working Group of Myocardial and Pericardial Diseases
Chairpersons: J. Veselka, V. Melenovský (Prague)
8:30
644.
TOXIC CARDIOMYOPATHIES
I. Málek (Prague)
8:45
645.
TAKOTSUBO CARDIOMYOPATHY
P. Kuchynka (Prague)
9:00
646.
PERIPARTUM CARDIOMYOPATHY
M. Lazárová (Olomouc)
9:15
647.
INFLAMMATORY CARDIOMYOPATHY
J. Krejčí (Brno)
9:30
648.
TACHYCARDIA-INDUCED CARDIOMYOPATHY
9:45
Discussion
10:00
Break
11:00-12:00
Congenital Heart Diseases:
The Path from Conception to Adult Cardiologist
Chairpersons: J. Popelová, T. Zatočil (Prague, Brno)
11:00 649.
.... BEFORE IT IS BORN (WHAT WE ALEREADY KNOW AND HOW WE DO IT, WHEN)
H. Jičínská (Brno)
11:15 650.
.... WHO ELSE IS TANDING BEFORE THE
V. Chaloupecký (Prague)
11:30 651.
.... WHAT CANNOT SURPRISE US (LATE COMPLICATIONS IN ADULTS)
11:45 652.
.... AND THEY ALSO WANT TO HAVE CHILDREN (PREGNANCY AND TRANSMISSION OF
HEART DISEASE)
T. Zatočil (Brno)
12:00
End of programme
8:30-9:30
Experimental Cardiology – Session 1
Chairpersons: M. Štengl, P. Ošťádal (Pilsen, Prague)
8:30
653.
OPENING SPEECH
8:40
654.
HEART RATE VARIABILITY IN PATIENTS WITH SEPSIS
M. Štengl (Pilsen)
8:50
655.
MICROCIRCULATION IN CARDIAC ARREST (FROM EXPERIMENT TO PRACTICE)
9:00
656.
CARDIAC TROPONINS AND PREDICTION OF MYOCARDIAL DAMAGE ON MODEL OF
CHRONIC ANTHRACYCLINE CARDIOMYOPATHY
M. Adamcová (Hradec Králové)
9:10
657.
EFFECT OF EXTRACORPOREAL MEMBRANE OXYGENATION ON LEFT VENTRICULAR
FUNCTION IN CARDIOGENIC SHOCK
9:20
658.
9:30-10:30
SEX DIFFERENCES IN THE COURSE OF CHRONIC HEART FAILURE: STUDY ON RAT
MODEL
L. Červenka (Prague)
Experimental Cardiology - Block II
Chairpersons: B. Ošťádal, M. Mlček (Prague)
9:30
659.
EPOXYEICOSATRIENOIC ACIDS, NEW THERAPEUTIC APPROACH IN TREATMENT OF
ACUTE MYOCARDIAL INFARCTION AND CHRONIC HEART FAILURE
J. Neckář (Teplice)
9:42
660.
EXTRACORPOREAL MEMBRANE OXYGENATION AND PULMONARY FUNCTION
M. Mlček (Prague)
9:54
661.
CARDIOVASCULAR SIDE EFFECTS OF ANTIPSYCHOTIC MEDICATION: FROM MODEL TO
PATIENT AND BACK
T. Stračina (Brno)
10:06 662.
MINI-INVASIVE INTERVENTIONS FOR LEFT VENTRICULAR REMODELING
P. Neužil (Prague)
10:18 663.
EFFECT OF LONG-TERM PHOSPHODIESTERASE-5A INHIBITION ON RIGHT AND LEFT
VENTRICULAR REMODELING IN CHRONIC VOLUME OVERLOAD
10:30
Break
11:00-12:00
Free Lectures - Emergencies in Cardiology
Chairpersons: T. Janota, A. Krüger (Prague)
11:00 664.
EFFECT OF SELENIUM SUPPLEMENTATION ON OXIDATIVE STRESS AFTER CARDIAC
ARREST: FIRST DATA OF RANDOMIZED PROSPECTIVE TRIAL
M. Janotka, D. Vondráková, P. Ošťádal, A. Kruger, J. Pánková, P. Hladká, H.
Zpěváčková, P. Neužil (Prague)
11:10 665.
IMPORTANCE OF RENAL-FUNCTION PARAMETERS IN OUTCOME PREDICTION AFTER
CARDIOPULMONARY RESUSCITATION FOR CARDIAC ARREST CAUSED BY
VENTRICULAR FIBRILLATION COMPLICATING ACUTE MYOCARDIAL INFARCTION
M. Hutyra, J. Přeček, J. Jarkovský, O. Moravec, D. Vindiš, R. Kopecká, D. Hetclová, T.
Adam, D. Šaňák , M. Táborský (Olomouc, Brno)
11:20 666.
ASSESSEMENT OF OXIDATIVE STRESS MARKERS AND THEIR USE FOR EARLY
PREDICTION OF PROGNOSIS IN PATIENTS AFTER CARDIAC ARREST
D. Vondráková, P. Ošťádal, M. Průcha, A. Krüger, M. Janotka, P. Neužil (Prague)
11:30 667.
REGISTRY OF OUT-OF-HOSPITAL CARDIAC ARREST WITH SUCCESSFUL RESUSCITATION
IN REGIONAL CARDIAC CENTRE
J. Seiner, R. Polášek, T. Roubíček, N. Suková, K. Krejbichová, O. Černý, J. Karásek
(Liberec)
11:40 668.
COGNITIVE DEFICIT AND PSYCHOSOCIAL FACTORS AFTER CARDIAC
ARREST
V. Dostálová, J. Bělohlávek, M. Pretl, O. Bezdíček, K. Sedláček (Prague, Paha)
11:50 669.
HYPERINVASIVE APPROACH PROLONGS TIME FOR FAVORABLE SHORT-TERM
OUTCOME IN REFRACTORY OHCA. PILOT RESULTS OF THE “PRAGUE STUDY“
J. Bělohlávek, H. Skalická, O. Šmíd, O. Franěk, A. Linhart (Prague)
12:00
End of programme
8:30-9:30
Chairpersons: P. Peichl, A. Stárek (Prague)
8:30
670.
ULTRASOUND-GUIDED VASCULAR CANNULATION IN ELECTROPHYSIOLOGY
LABORATORY - INITIAL EXPERIENCES
P. Peichl, B. Aldhoon, D. Wichterle, R. Čihák, J. Kautzner (Prague)
8:40
671.
ANALYSIS OF CARDIAC TROPONIN T IN PATIENTS ADMITTED FOR ATRIAL
FIBRILLATION
M. Čaprnda, M. Kováčová, M. Potočárová, M. Filková (Bratislava, SR)
8:50
672.
NON-INVASIVE ABLATION OF VENTRICULAR TACHYCARDIA, LONG-TERM EFFICACY
R. Neuwirth, J. Cvek, D. Feltl, M. Fiala (Třinec, Ostrava)
9:00
673.
ANALYSIS OF TROPONIN T LEVEL CHANGES AFTER ABLATION OF VENTRICULAR
TACHYCARDIA BY STEREOTACTIC RADIOTHERAPY, SUCCESSFUL WAY TO OUTPATIENT
PROCEDURE
R. Neuwirth, J. Cvek, D. Feltl, M. Fiala (Třinec, Ostrava)
9:10
674.
RUTINE USE OF INTRACARDIAC ECHOCARDIOGRAPHY IN RADIOFREQUENCY
ABLATION OF ATRIAL FLUTTER. RANDOMIZED TRIAL.
D. Heřman, J. Žďárská, P. Osmančík (Prague)
9:20
675.
LONG-TERM OESOPHAGEAL MOBILITY FROM 3D ROTATIONAL ANGIOGRAPHY
(3DRA) OF LEFT ATRIUM AND CARDIAC COMPUTED TOMOGRAPHY (CT);
CONSEQUENCES FOR CATHETER ABLATION OF ATRIAL FIBRILLATION
Z. Stárek, F. Lehar, J. Jez , J. Wolf, A. Žbánková, T. Kulík (Brno)
9:30-10:30
Free Lectures - Echo, Valvular Heart Diseases, Miscellaneous
Chairpersons: Š. Černý, F. Holm (Prague)
9:30
676.
ELIMINATION OF MITRAL REGURGITATION BY REDUCTION OF SAGITTAL SIZE
OF MITRAL ANNULUS BY MEANS OF TRANSVALVULAR INTRAANNULAR IMPLANT
MITRAL BRIDGE (TM) – MID-TERM RESULTS
Š. Černý, V. Subramanian, M. Benešová, K. Mžourková , I. Skalský, P. Neužil (Prague,
Morgan Hill, United States)
9:40
677.
RESULTS OF 5-YEAR-FOLLOW-UP OF PATIENTS AFTER TAVI, ANALYSIS OF
ECHOCARDIOGRAPHIC AND CLINICAL DATA
R. Petr, H. Línková, E. Pašková, V. Kočka, P. Toušek (Prague)
9:50
678.
LATE COMPLICATIONS AFTER ASCENDING AORTA REPLACEMENT - ROLE OF IMAGING
METHODS
H. Línková, R. Petr, E. Pašková (Prague)
10:00 679.
EVALUATION OF BENEFITS OF MAGNETIC RESONANCE IMAGING IN DIAGNOSIS AND
TREATMENT OF HEART DISEASES
R. Bánszky, M. Solař, J. Žižka, L. Klzo, Z. Bělobrádek (Hradec Králové)
10:10 680.
ROLE OF ECHOCARDIOGRAPHY IN DIAGNOSIS OF TRANSIENT DYNAMIC LEFT
VENTRICULAR OUTFLOW TRACT OBSTRUCTION IN ACUTE PHASE OF TAKOTSUBO
CARDIOMYOPATHY
F. Holm, M. Babický, M. Erbrt (Prague)
10:20 681.
LEFT ATRIAL STRAIN IS HIGHLY PREDICTIVE OF PULMONARY ARTERY PRESSURES IN
PATIENTS WITH AORTIC STENOSIS
J. Eicher, N. Yameogo, L. Aho, J. Philip, G. Laurent, P. Dobšák (Brno)
10:30
Break
11:00-12:00
Chairpersons: P. Osmančík, T. Skála (Prague, Olomouc)
11:00 682.
PERICARDIAL FAT THICKNESS IS RESPONSIBLE FOR FREQUENT PRESENCE OF GAPS IN
THE ROOF LINE OF THE LEFT ATRIUM AFTER THORACOSCOPIC EPICARDIAL ABLATION
FOR ATRIAL FIBRILLATION BY LINEAR CETHETER COBRA FUSION
P. Osmančík, P. Budera, D. Heřman, J. Žďárská, R. Petr, Z. Straka (Prague)
11:10 683.
COMPLICATIONS OF INTERVENTIONAL ELECTROPHYSIOLOGICAL PROCEDURES IN
PATIENTS ON LONG-TERM TREATMENT WITH NOACs AS PREVENTION OF
THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION
P. Neužil, J. Matoušková, P. Hála, L. Šedivá, J. Petrů, J. Škoda, M. Janotka, M.
Chovanec (Prague)
11:20 684.
LONG-TERM RESULTS OF CATHETER ABLATION OF VENTRICULAR TACHYCARDIA IN
NON-ISCHEMIC CARDIOMYOPATHIES
M. Hrošová, M. Fiala, J. Chovančík, R. Neuwirth, O. Jiravský, Š. Krawiec, D. Vavřík, J.
Gorzolka, J. Pindor, J. Januška (Třinec)
11:30 685.
CATHETER ABLATION OF FOCAL ATRIAL TACHYCARDIA ORIGINATING FROM
INTERATRIAL SEPTAL REGION: ONE CENTRE´S EXPERIENCE
B. Aldhoon, P. Peichl, D. Wichterle, R. Čihák, J. Kautzner (Prague)
11:40 686.
OUR EXPERIENCE WITH CATHETER-BASED TREATMENT OF RECURRENCE OF ATRIAL
FIBRILLATION (AFIB) AND ATRIAL TACHYCARDIA (AT) IN PATIENTS AFTER SURGICAL
TREATMENT OF AFIB
M. Janotka, L. Šedivá, J. Petrů, J. Škoda, M. Chovanec, J. Brada, P. Neužil (Prague)
11:50 687.
EFFICACY OF CATHETER ABLATION FOR ATRIAL FIBRILLATION ASSESSED BY
IMPLANTABLE ECG MONITOR
T. Skála, O. Moravec, M. Hutyra, M. Fedorco, Z. Tudos, M. Táborský (Olomouc)
12:00
End of programme

The programme of 24th Annual Congress of the Czech Society of

Transkript

Podobné dokumenty

Výsledková listina, úkoly List of results, tasks

IX. slovenské a české sympózium o arytmiách a kardiostimulácii XIII

Metodika hodnocení přirozenosti lesů v ČR

Vemeno – Teat - Rallye Rejvíz 2014

Bakalářská práce Popis programových celků pro tvorbu

Kuchař – Cook - Rallye Rejvíz 2014

LÉKAŘSKÉ SIMULÁTORY Jiří Kofránek, Tomáš Kulhánek

Otázky O hubnutí

Výsledková listina, úkoly List of results, tasks

Výsledková listina, úkoly List of results and tasks

Startovní listina a úkoly RR 2013

Výroční zpráva 2012 - Fakulta zdravotnických studií